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Life is all about making the right decisions at the right time. Consequently, cells 
have evolved to “read” external signals, process this information and make decisions 
through a vast array of signaling molecules. Kinases are a key class of these signaling 
molecules that interact with other signaling molecules precisely in space and time to form 
exceedingly complex and dynamic signaling networks. As a result, these networks abound 
in non-linear connections leading to the emergence of interesting spatial and temporal 
changes in signaling activities such as oscillations. However, these are not just 
academically interesting emergent phenomena; cells have evolved to exploit such 
dynamics of signaling in space and time to process information efficiently and regulate 
crucial cellular processes ranging from insulin secretion to cellular adhesion. How kinase 
signaling networks help cells process information through such spatiotemporal dynamics 
is the central question of this dissertation. 
We used a combination of modeling and experimentation to understand how 
kinases process information. In pancreatic beta-cells, information is conveniently encoded 
in the form of calcium oscillations. We found that the same input calcium signal may be 
decoded in different ways by distinct downstream pathways. This differential decoding 
may be optimized for regulating various cellular functions. Protein Kinase A (PKA) and 
calcium form a tightly integrated oscillatory circuit with the ability to tune temporal 
features of the oscillations. Such temporal modulation enables PKA to change its mode of 
action. The Extracellular-signal regulated kinase (ERK) cascade on the other hand employs 
sequential processing that integrates the calcium signals so as to produce sustained pathway 
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outputs. In neuroendocrine PC12 cells, ERK not only displays interesting temporal 
dynamics, but striking spatial differences as well. Such spatiotemporal differences manifest 
as a result of complex kinase-interaction networks, and these differences help to optimally 
regulate multiple cellular processes simultaneously. 
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Chapter 1 Introduction1 
1.1 Cellular information processing through signaling 
dynamics 
Cells use signaling cascades to make critical and complicated decisions in response 
to external stimuli in multiple contexts – apoptosis, metabolism and migration, to name a 
few. However, the process of cellular signaling in its most elemental form comprises 
nothing but a set of chemical reactions – perhaps, an old phenomenological remnant from 
the days of proto-cells which were likely little more than membranous bags of reacting 
molecules (1). Evidently there is a mismatch between the complexity of functional 
responses and the apparent simplicity of the underlying molecular mechanisms.  During the 
course of evolution, life forms have bridged this gap primarily in two ways: a) by 
expanding the repertoire of signaling molecules (e.g., various posttranslationally modified 
forms and splice variants), and b) by exploiting temporal and spatial variations to diversify 
the portfolio of responses using the same set of signaling molecules.  
Temporal changes in concentrations or activities of effector molecules in a 
signaling cascade occur commonly in response to external stimuli. Depending on the 
architecture of the signaling network, these temporal changes may be precisely controlled 
and coordinated to exhibit complex dynamics such as adaptation or oscillations. 
Oscillations, in fact, commonly occur in many organisms ranging from unicellular bacteria 
                                                 
1 A version of this chapter has been published and appears in: Ganesan A and Zhang J. 
How cells process information: quantification of spatiotemporal signaling dynamics. Protein 
Sci. 2012, 21(7):918-928.  
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to complex mammalian cells. Temporal oscillations are thought to regulate metabolism (2, 
3), cell cycle (4), circadian rhythms (5, 6), and rhythmic beating of the heart (7) among 
many other physiological processes. Alternately, signaling cascades could translate 
information about external stimuli to spatial dynamics of signaling molecules influencing 
a variety of cellular processes including cardiac function (8) and cell migration (9).  
Understanding the biophysical bases of spatiotemporal dynamics of signaling is therefore 
important in appreciating how cells process information from external cues to regulate 
cellular processes of biomedical importance. Researchers have been able to uncover 
mechanisms underlying signaling dynamics using a vast array of experimental tools and 
modeling approaches, some of which I briefly outline in the following sections.  
1.2 Experimental tools for monitoring signaling dynamics 
Monitoring most signaling molecules such as kinases, phosphatases and 
cytoskeletal proteins often requires cell lysis or fixation followed by immunoblotting and 
immunocytochemistry, where real time information is often lost (10-14). The advent of 
fluorescent protein (FP) technology combined with advancements in microscopy has 
however largely addressed these issues by making it possible to observe signaling 
dynamics in live-cell context with millisecond temporal resolution and tens of nanometer 
spatial resolution. An important frontier of this technology has been the development of 
suites of genetically encoded fluorescent biosensors for monitoring spatiotemporal 
dynamics of signaling molecules.  
A popular class of single FP-biosensors like the GCaMP family of calcium 
indicators exploits changes in fluorescence of individual fluorophores to indicate 
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physiological events (15, 16). Single FP biosensors however are intensity based and are 
susceptible to motion artifacts, variations in intensity of excitation light and other optical 
parameters, and can therefore be complemented by ratiometric indicators, for instance 
exploiting Fӧrster Resonance Energy Transfer (FRET) between a fluorophore pair. Many 
FRET-based biosensors have been developed for kinases and successfully employed to 
understand kinase biology (17). A typical FRET-based kinase activity reporter (KAR) (18-
21) consists of a substrate peptide and a phospho-amino acid binding domain ‘sandwiched’ 
between two FPs. Phosphorylation of the substrate by the kinase of interest and the 
subsequent binding of the phosphorylated substrate to the phospho-amino acid binding 
domain results in a change in the distance and/or relative spatial orientation of the two FPs 
and hence a change in FRET between them (Figure 1.1). The KARs have become a 
valuable tool in elucidating mechanisms of kinase-mediated signaling regulation.  
 
Figure 1.1: Schematic of FRET-based Kinase Activity Reporter. 
Foremost among such kinases are the Protein Kinase A (PKA) and the 
Extracellular-signal Regulated Kinase (ERK) which have been implicated in virtually 
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every cell function. PKA activity dynamics, observed in real-time using the A Kinase 
Activity Reporter (AKAR) has helped us understand its role in cell migration (22), cardiac 
rhythm (8) and neuronal functions (23). The ERK activity dynamics measured using the 
ERK Activity Reporter (EKAR) has been used to uncover its role in long-term potentiation 
(24), neuronal development (25) and regulation of cell cycle (26). These biosensors have 
helped us in our attempts to understand how kinases process information through 
spatiotemporal dynamics to regulate pancreatic beta-cell and neuroendocrine cell 
functions, as explained in Chapters 2-4. 
1.3 Computational modeling-aided approaches to discern 
signaling dynamics 
Apart from a host of experimental tools detailed above, computational modeling is 
increasingly becoming an indispensable resource for researchers studying signaling 
dynamics. Quantitative models are especially helpful in the case of large signaling systems 
in which individual components interact in ways that may not be completely predictable 
based on the properties of these components studied separately, but may instead acquire 
emergent properties endowed by complex intermolecular interactions. Such, systems-level 




Figure 1.2: Modeling-driven dissection of signaling networks. Known non-linear 
connections (denoted by dark lines) in a network comprising three components A, B, and 
C are represented by a mathematical model. In this network, A activates B, B activates C, 
and C inhibits A in a negative feedback manner. Simulations of the model can then be 
matched with the experimental data. Any discrepancies between experiments and model 
can indicate the need for further improvements to the model, typically involving a 
revision of parameter values. Simulations can also reveal the presence of new 
connections (shown in dotted lines) leading to the formulation of a more complete 
network which can better explain experimental results. 
In particular, the emergent properties can engender complex dynamical responses, 
including oscillations or multistability (27, 28), requiring modeling approaches for in depth 
understanding and analysis. Further, models can be powerful tools in generating and testing 
hypotheses quickly and inexpensively, leading to rational design of subsequent 
experiments. Models can also be powerful in generating quantitative paradigms integrating 
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diverse data into a single framework, and helping abstract the underlying evolutionary 
‘design’ principles of signaling networks (29, 30), which may be subsequently used in 
reverse engineering of novel signaling networks (31, 32). 
Biological signaling reactions, like their chemical counterparts, are subject to the 
laws of mass action and can therefore be mathematically represented in the form of 
ordinary differential equations (ODEs). An ODE, describing the rate of change of 
concentration of a molecular species, captures the balance (or imbalance) between the 
synthesis and degradation of a particular species, or its activation/inactivation through 
chemical modification. A system of ODEs can therefore theoretically predict the changes 
in the concentrations of the modeled species over various periods of time.  ODE models 
have been widely used to describe temporal dynamics of signaling pathways. However, 
signaling molecules also exhibit spatial dynamics which can be important functionally. 
Arguably, the easiest approach to model spatial and temporal dynamics is to use ODE-
based compartmentalized models. In such models, the cell is assumed to consist of different 
discrete compartments such as the plasma membrane, cytosol and nucleus. Temporal 
dynamics in each compartment is described by a separate set of ODEs, and a different set 




   
Figure 1.3: A representative compartmentalized model of spatial and temporal dynamics 
of the activity of a species, A. The cell is divided into two homogenous compartments: the 
cytosol and the nucleus. A is generated and degraded in the cytosol at rates kfc and krc, 
respectively, and is generated and degraded in the nucleus at rates kfn and krn, 
respectively. Further, A is assumed to shuttle between the two compartments at effective 
rates of kcn and knc. Separate ODEs for each compartment are written by summing up the 
reaction and diffusion rates. 
1.4 Temporal dynamics 
Intracellular responses to an external stimulus often involve temporal changes in 
concentrations or activities of specific signaling molecules. Cells have therefore evolved 
to use variations in temporal dynamics as a means of inferring and reacting to external 
stimuli. Cellular signaling cascades are complex systems embedded with non-linearities in 
the form of feedback loops. Given the right conditions, a circuit with a negative feedback 
loop can produce diverse responses ranging from simple adaptation to complex oscillations 




Figure 1.4: Temporal dynamics of signaling circuits with negative feedback loops in a 
representative system comprising two molecules, X and Y. (A) The presence of a negative 
feedback loop alone can produce a transient adaptive output signal in response to a 
“step-input” signal. (B) Negative feedback loop coupled with time-delay [represented 
explicitly as Y(t) = X(t-)] produces a damping oscillation in response to a ‘‘step-input’’ 
signal. (C) Negative feedback with time-delay (represented by the presence of an extra 
species, Z in the circuit) coupled with additional positive feedback loops results in 
sustained oscillations in response to a ‘‘step-input’’ signal. Positive feedback loops are 
denoted in green. Negative feedback loops are denoted in red. 
Oscillations can be a rich means of communication within the cells. Cells may use 
the same oscillating signal to convey different outcomes through simple changes in the 
parameters of oscillations such as frequency and amplitude (33, 34). Calcium oscillations, 
have been linked to, among many other things, memory formation (35, 36), insulin 
secretion (37, 38) and cardiac rhythm (39). Oscillations in ERK activity have been posited 
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to influence cell cycle entry and hence cell proliferation (26). The transcription factor 
Nuclear Factor kappa B (NF-B) exhibits complex oscillatory behavior which is thought 
to influence mammalian inflammatory immune responses (40, 41). Experimental 
monitoring of such temporal dynamics of signaling activities has been successfully used in 
conjunction with computational models to address fundamental questions pertaining to 
intracellular communication. In Chapters 2 and 3, I demonstrate how such approaches 
helped us understand how temporal signaling dynamics of PKA and ERK enable pancreatic 
beta-cells to process information. 
1.5 Spatial dynamics 
Simplistic models often assume cells to be homogeneous “bags” of molecules. 
While this first order of approximation may be sufficient to explain many temporal aspects 
of signaling, a cell, in reality, is made up of spatially restricted organelles and 
compartments that perform pre-defined sets of functions.  To achieve spatially distinct 
signals, the cell employs different mechanisms ranging from use of organelle-specific 
signaling molecules and pathways to modulation of different pools of spatially universal 
signaling molecules such as calcium. Precise spatial dynamics of signaling is achieved by 
a combination of physical processes (diffusion), chemical factors (balance between the 
rates of synthesis and degradation of the signaling molecules) and structural factors 
(cellular structures, and scaffold or anchor proteins in the context of protein complexes) to 
sequester molecules in defined locations.  
Spatial dynamics of second messenger molecules exemplified by calcium and 
cyclic adenosine monophosphate (cAMP) microdomains have been studied extensively. 
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Calcium ‘sparks,’ for instance are widely recognized to be the unitary events underlying 
the excitation-contraction coupling process and arise from spontaneous or evoked opening 
of a cluster of Ryanodine receptors (RyRs) resulting in local increases in calcium 
concentration (42, 43). The second messenger molecule, cAMP, also exhibits intricate 
spatial dynamics influencing cardiomyocyte contractility. Compartmentation of cAMP 
signaling and the resulting gradients in the activity of the effector, PKA have been directly 
observed using fluorescent reporters (41, 43-45). Combining such experimental 
approaches with modeling, Saucerman et al. (8) identified potential signaling mechanisms 
for regulating spatial PKA activity dynamics. Both PKA mediated buffering of cAMP and 
restricted cAMP diffusion mediated by cAMP-degrading phosphodiesterases (PDEs) help 
establish the phosphorylation gradients.  
1.6 Aims and significance 
Cells are complex dynamic entities that register, react and respond to changing 
external conditions. This processing of the external information and subsequent decision 
making processes are carried out by signaling molecules, in significant part through the 
temporal and spatial dynamics of signaling as detailed in the preceding sections. A major 
class of such signaling molecules are kinases which are thought to regulate about 30 % of 
the human proteome (46). However, how the spatiotemporal dynamics of kinase signaling 
activities influences cellular decision making capacity is still largely unclear. Therefore, in 
this thesis I set out to answer three major questions, each of which is addressed in a separate 
aim as detailed below:  
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1. How do cells use temporal kinase activity dynamics to modulate the 
capacity of signaling output? 
2. How are temporally complex signals decoded by kinases? 
3. How do spatial dynamics of kinase activity influence cellular function? 
1.6.1 Specific Aim 1: To study effects of temporal PKA dynamics in 
pancreatic beta-cells 
The cAMP-dependent Protein Kinase (PKA) is a prototypical kinase that influences 
action potential propagation via modulation of calcium channels and cardiomyocyte 
contractility (47, 48). The cAMP signaling pathway modulates glucose-dependent insulin 
secretion; however the molecular details are beginning to emerge only recently. We 
hypothesized that cAMP actions in pancreatic beta-cells may be effected through PKA. In 
this aim, we discovered oscillations in PKA activity and built a mathematical model to help 
us predict the role of PKA in modulating calcium dynamics. Our model simulations 
predicted that PKA not only initiates but also frequency-modulates intracellular calcium 
oscillations via a feedback loop which was subsequently confirmed through experiments. 
Furthermore, our results suggest that decoding of intracellular calcium oscillations by PKA 





1.6.2 Specific Aim 2: To investigate the temporal ERK dynamics in 
pancreatic beta-cells 
The extracellular signal-regulated protein kinase 1/2 (ERK1/2) is a central signaling 
molecule that has been shown to influence cell survival and proliferation in many systems 
including beta-cells (49, 50). Upon glucose stimulation, ERK1/2 is activated in a calcium-
dependent manner, and activated ERK phosphorylates and modifies the function of 
transcription factors that regulate insulin gene transcription and cell survival (51-53). 
Characterization of ERK-calcium crosstalk and dissecting the molecular mechanisms that 
underlie this crosstalk are essential to ultimately understanding how pancreatic beta-cell 
health including survival and proliferation is affected. In this aim, we uncovered the 
mechanisms of calcium-dependent ERK1/2 activation and discovered that information 
transfer down the ERK cascade has a direct bearing on the signaling versatility of the 
cascade.  
1.6.3 Specific Aim 3: To understand the role of spatial ERK signaling 
dynamics on cell function 
The ERK signaling system in the neuroendocrine pheochromocytoma PC12 cells 
is a classical model that highlights how temporal signaling dynamics influences cell fate. 
An EGF stimulus results in transient ERK activity which leads to cell proliferation. On the 
other hand, exposing the cells to NGF causes them to differentiate due to sustained ERK 
activity. While the temporal aspects of ERK signaling have been studied in detail, the 
spatial dynamics of ERK signaling is largely unknown. Using genetically encoded 
biosensors specifically targeted to different sub-cellular organelles of PC12 cells, we 
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discovered that distinct spatial activity patterns are evoked for the same stimulus. In this 
aim, we investigated the mechanisms that result in this differential spatial pattern and 















Chapter 2 Signaling diversity of PKA achieved via 
a calcium-cAMP-PKA oscillatory circuit2  
2.1 Introduction 
Protein kinases serve as major information transducers in cells and are responsible 
for regulating diverse cellular functions (54, 55). However, the molecular mechanisms 
underlying this signaling diversity are not well understood, particularly with regard to the 
role of the spatiotemporal regulation of kinases. Although important progress has been 
made towards understanding of the spatial compartmentalization of kinases (56, 57), much 
less is known about how temporal regulation of kinase action can be exploited to encode 
diverse signals and control different functional outcomes (58). 
PKA, a prototypical protein kinase (59), plays a host of important roles in a variety 
of cellular locations. Among these is the regulation of calcium-triggered exocytosis at the 
cell membrane, a process critical to many cellular functions (60). In pancreatic beta cells, 
exocytosis is critical for the pulsatile insulin secretion that is regulated by a variety of 
stimuli, including electrical, metabolic and hormonal signals (61, 62). Calcium influx is 
stimulated when glucose metabolism produces an increase in the [ATP]/[ADP] ratio that 
inhibits K-ATP channels and induces membrane depolarization, leading to the opening of 
voltage-gated calcium channels. When activated either by glucose (63) via calcium or by 
                                                 
2 A version of this chapter has been published and appears in: Ni Q*, Ganesan A*, Aye-
Han NN*,Gao X, Allen MD, Levchenko A, Zhang J. Signaling diversity of PKA achieved 
via a Ca2+-cAMP-PKA oscillatory circuit. Nat Chem Biol. 2011, 7(1):34-40.  
* denotes co-first authorship 
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hormones such as glucagon-like peptide 1 via classical G protein–coupled receptor 
signaling (62), PKA can in turn modulate the calcium signal (64, 65) and also directly 
influence exocytotic insulin release (60). For instance, a PKA-dependent mechanism 
operates during the initial phase of glucose-induced exocytosis (66), and impairment of 
this process has been implicated in the pathogenesis of type 2 diabetes (67). 
Here, we investigated the role of the temporal regulation of PKA in integrating and 
transducing a variety of signals. By combining fluorescent biosensor-based live-cell 
tracking of signaling activities with mechanistic modeling, we demonstrate that PKA 
exhibits oscillatory activity and, together with calcium and cAMP, forms a highly 
integrated oscillatory circuit in MIN6 beta cells. The organization of this oscillatory circuit 
allows PKA to modulate the frequency of oscillation, to integrate input signals and to exert 
spatiotemporal control of substrate phosphorylation. This demonstration of a functional 
role for the temporal regulation of a protein kinase in achieving signaling diversity helps 
to establish a new model for encoding signaling information within temporal patterns, such 
as the frequency of oscillation of an enzymatic activity. 
2.2 Results 
2.2.1 Oscillatory PKA activity 
We first set out to monitor the time profile of PKA activity changes in MIN6 
pancreatic beta-cells in response to the K+ channel blocker, tetraethyl ammonium chloride, 
TEA which mimics glucose action. Calcium and cyclic adenosine monophosphate (cAMP) 
are both known to oscillate in beta-cells in response to glucose or TEA stimulation (68). 
However, the dynamics of the primary effector of cAMP, PKA was unknown. The PKA 
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activity dynamics are governed by the activation and deactivation kinetics of PKA. As a 
result, a wide range of PKA activity responses are possible, in theory at least, ranging from 
oscillatory to integrated responses (Figure 2.1A) with different implications for regulating 
cellular processes.  
  
Figure 2.1: Oscillatory changes in PKA activity in single MIN6 beta cells.  A.  Simulation 
of PKA activity in the presence of oscillatory cAMP, showing different activity patterns 
depending on the characteristics of the oscillations and parameters of PKA activation 
and deactivation. A parameter reflecting the binding of cAMP to PKA homodimer was 
varied in this simulation. k1 is the ratio of the new value to the nominal value of this 
parameter. Norm. conc., normalized concentration; PKA*, active PKA. B.  Phospho-
immunoblot analysis using an anti-phospho PKA substrate antibody showed sustained 
increases in substrate phosphorylation by PKA upon TEA treatment of MIN6 β-cells. C. 
A representative time course of yellow/cyan emission ratio changes in single MIN6 beta 
cells expressing AKAR, a FRET-based PKA activity reporter, revealed single-cell PKA 
activity oscillations (n = 21). 
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Therefore, we decided to experimentally determine the PKA activity dynamics. 
Accordingly, MIN6 cells were treated with TEA (20 mM), lysed at different time points 
and the PKA activity probed through the phospho-PKA substrate antibody. We observed a 
sustained and elevated PKA activity response to TEA (Figure 2.1B), suggesting that PKA 
activity might not conform to cAMP oscillations or that the oscillatory PKA activity is 
masked at the cell-population level. To analyze the temporal dynamics of PKA at the 
single-cell level, we performed fluorescence imaging of endogenous PKA activity using a 
genetically encoded A-kinase activity reporter (AKAR) (69, 70). In contrast to the 
population level experiments, this analysis revealed oscillatory PKA activity (Figure 2.1C), 
suggesting a repetitive shifting of the balance between the actions of PKA and 
counteracting phosphatases in single cells. These oscillations occurred with a period of 1–
6 min in >60% of AKAR-expressing MIN6 cells (n = 21), matching the frequency of the 
calcium oscillation patterns previously reported in these cells (68). Therefore, PKA activity 
exhibits oscillatory changes in single MIN6 cells, which were likely masked in cell 
population studies because the observed oscillations in PKA activities were asynchronous, 
varying in phase and frequency among individual cells.  
2.2.2 Synchronized oscillations of PKA, calcium and cAMP 
Given that calcium is known to oscillate under the same conditions and to serve as 
an important signal in beta cells, we characterized the temporal correlation between PKA 
activity and calcium dynamics by performing coimaging experiments using AKAR in 
conjunction with the calcium dye Fura-2 (71) in single MIN6 cells. For these experiments, 
we engineered a red-shifted AKAR, AKAR-GR (Figure 2.2), based on enhanced GFP and 
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the red fluorescent protein mCherry (referred to here as RFP), to allow better signal 
separation from Fura-2.  
 
Figure 2.2: Schematic and representative time course of AKAR-GR upon Fsk stimulation 
in HEK-293 cells. 
We found that the PKA oscillations and calcium oscillations were ‘in register’ with 
each other (Figure 2.3B). Notably, during each cycle of oscillation, the rise in the calcium 
transient appeared to follow, with a noticeable lag, the accumulation of PKA activity. This 
pattern likely reflected the PKA-mediated potentiation of calcium influx via voltage-gated 
calcium channels and/or inositol trisphosphate receptors (IP3R) (72, 73). Moreover, the 
decrease in PKA activity in each cycle was surprisingly rapid when compared to the 
transient PKA activities observed in other cell types (Figure 2.4A) (74), and it was 
precisely correlated with the declining phase of the calcium spike, suggesting that there is 
a calcium-dependent mechanism in place to ensure the rapid downregulation of and/or 




Figure 2.3: Oscillatory changes in PKA activity, cAMP and calcium dynamics are highly 
coordinated in MIN6 cells.  A. Domain structures of ICUE-YR, AKAR-GR and a single-
chain dual-specificity biosensor, ICUEPID, for PKA activity and cAMP dynamics. B. 
(Top) Fluorescence images of MIN6 cells expressing AKAR-GR loaded with Fura-2. 
(Bottom) Representative time courses showing coordinated oscillations in PKA activity 
(monitored by AKAR-GR, red) and calcium (monitored by Fura-2, black) in single MIN6 
cells. Scale bar, 10 μm. C. (Top) Fluorescence images of a MIN6 cell expressing ICUE-
YR loaded with Fura-2. (Bottom) Representative time courses showing coordinated 
oscillations in cAMP (monitored by ICUE-YR, red) and calcium (monitored by Fura-2, 
black) in single MIN6 cells. Scale bar, 10 μm. D. (Top) Fluorescence images of a MIN6 
cell expressing ICUEPID. (Bottom) Representative time courses showing coordinated 
oscillations in PKA activity (red) and cAMP (black) monitored by ICUEPID in single 
MIN6 cells. Scale bar, 10 μm. E. Simulation of the model showing calcium (black) and 
active PKA (PKA*, red) oscillations. F. Simulation of the mathematical model showing 
calcium (black) and cAMP (red) oscillations. G. Simulation of the model showing cAMP 
(black) and active PKA (PKA*, red) oscillations. Norm. emission, normalized emission; 
norm. conc., normalized concentration. Normalization in simulations made with respect 




Figure 2.4: AKAR and ICUE responses. A. Representative time course of AKAR response 
upon isoproterenol stimulation in HEK293 cells B. Representative cAMP response to 
TEA in MIN6 cells measured using the cAMP biosensor, ICUE. 
In MIN6 cells, calcium-dependent regulation of PKA can occur through calcium-
dependent adenylate cyclases and phosphodiesterases (PDEs) (74), the enzymes that 
produce and degrade cAMP, respectively. Indeed, as previously observed (68), cAMP was 
found to oscillate under the same conditions when visualized with a fluorescent cAMP 
indicator, ICUE (75, 76) (Figure 2.4B). Simultaneous imaging using a red-shifted ICUE, 
ICUE-YR (Figure 2.3A) and Fura-2 in single MIN6 cells confirmed that these cAMP 
oscillations are highly synchronized with the calcium oscillations (Figure 2.3C).  
The high degree of synchronization between PKA and calcium and between cAMP 
and calcium suggested that all three components were regulated in a temporally 
coordinated fashion. As PKA activity is often compartmentalized in various systems, we 
asked whether the cAMP and PKA oscillations were also correlated in the local cellular 
context. To answer this question, we took advantage of a new single-chain dual-specificity 
biosensor for parallel detection of PKA activity and cAMP dynamics (Figure 2.3A). This 
biosensor contains both cAMP-sensitive and PKA-dependent molecular switches and can 
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simultaneously capture the dynamics of two signaling events in the same local 
environment, thereby facilitating quantification and correlation of these signaling 
activities. In MIN6 cells expressing this single-chain dual-specificity biosensor, TEA 
treatment elicited oscillatory signals from both reporting units (Figure 2.3D). These 
oscillations were highly temporally coordinated, with cAMP rises always preceding 
increases in PKA activity, suggesting that oscillations in PKA activities are indeed locally 
driven by oscillatory changes in cAMP levels. 
2.2.3 Analysis of the calcium-cAMP-PKA oscillatory circuit 
The precise temporal correlation between the oscillatory activities of calcium, 
cAMP and PKA suggests a complex underlying mechanism involving multiple feedback 
interactions. To better understand this signaling circuit, we constructed a mathematical 
model (See Section 2.4 for complete details) by incorporating a detailed description of the 
biochemical events involving these three key molecular components (77). In our model, 
the interplay between the membrane-potential regulation and calcium forms the first 
feedback loop, consistent with the Chay-Keizer model (78). A second feedback loop, 
centered around calcium, cAMP and PKA, was incorporated by explicitly introducing 
putative regulation of both voltage-gated L-type calcium channels and IP3R by active PKA 
(72, 73). Additional links needed to complete the model were introduced on the basis of a 
network topology analysis determining the minimal model sufficient to account for several 
qualitative features of our experimental findings (77).  When operating under assumptions 
about parameter values consistent with literature data, the model was able to capture the 
detailed dynamic relationships between various molecular components observed in our 
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experiments (Figure 2.3). Our combined experimental and modeling data therefore suggest 
the existence of a functional signaling circuit consisting of calcium, cAMP and PKA. In 
this circuit, the activities of all the components are temporally regulated in the form of 
synchronized oscillations, as a result of a tight coupling between these components through 
feedback interactions. 
2.2.4 Role of PKA in the oscillatory circuit 
To dissect the role of PKA in this oscillatory circuit, we examined the effects of 
altered PKA activity on the oscillatory patterns of the calcium-cAMP-PKA system. The 
model predicted that the oscillatory behavior of the system, as indicated by the calcium 
signal, would strongly depend on the level of PKA activity, although oscillation of PKA 
activity was not required for maintaining calcium oscillations (Figure 2.5). Inhibition of 
PKA activity was predicted to have strong abolishing effects on calcium oscillations 
(Figure 2.6A). Indeed, addition of the PKA inhibitor H89 to MIN6 cells rapidly terminated 
calcium oscillations, indicating that PKA activity was required (Figure 2.6B). Consistent 
with this observation, no TEA-induced calcium oscillations were observed in 17 of 24 cells 
in the presence of a specific PKA inhibitor, RFP-tagged PKI. This result represents a three-
fold reduction in oscillatory behavior compared to control cells, over 87% of which showed 
calcium oscillations (Figure 2.7). In contrast, the model predicted that increasing PKA 
activity would modulate the frequency of the calcium oscillations (Figure 2.8A). This 
prediction was tested by monitoring calcium dynamics when a general phosphodiesterase 
inhibitor, 3-isobutyl-1-methylxanthine (IBMX), was added to MIN6 cells after TEA-
induced calcium oscillations were established. We found that every cell showing regular 
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oscillations both before and after IBMX addition exhibited an increase in oscillation 
frequency (n = 15) (Figure 2.8B), demonstrating that cAMP-PKA activity can modulate 
the calcium oscillation frequency. 
 
Figure 2.5: Model simulation of membrane potential (Vm), calcium (Ca2+) and cAMP 
responses under constant PKA activity conditions. 
On the other hand, PKA-mediated phosphorylation is continuously counter-
balanced by phosphatase activity. For instance, PKA and phosphatase PP2B are known to 
have opposing effects on L-type calcium channels via phosphorylation and 
dephosphorylation of the channels, respectively (79). Our model predicted that changes in 
PP2B activity would have an effect opposite to that of PKA activity in terms of modulating 
the frequency of calcium oscillations (Figure 2.9A). Consistent with this prediction, 
treatment of MIN6 cells with 3 μM cyclosporine A, a PP2B inhibitor, increased the 
frequency of TEA-induced calcium oscillations (n = 7) (Figure 2.9B), indicating that the 





Figure 2.6: PKA activity is required for calcium oscillation and tunes its frequency.  A. 
Simulation of the model in the presence or absence of PKA (shaded region). B. The effect 
of inhibiting PKA by H89 (10 μM) on calcium oscillations. 
 
Figure 2.7: PKA inhibition affects calcium oscillations. Percentages with calcium 
oscillation for control cells, cells treated with H89 for 10 min or 20 min, and cells 




Figure 2.8: PDE inhibition modulates calcium oscillation frequency. A. Simulation of the 
model with increased feedback achieved when PDE activity is decreased (shaded region). 
B. The effect of adding a PDE inhibitor IBMX (100 μM) on calcium oscillations (n = 15). 
Notably, model simulations also showed that when compared to the calcium 
oscillation amplitude, the oscillation frequency was considerably more sensitive to changes 
in PKA activity (Figure 2.10). This finding suggests a role for PKA as a frequency 
modulator. Taken together, these data suggest that PKA activity can directly modulate the 
oscillatory patterns of the calcium-cAMP-PKA signaling circuit, thereby affecting cellular 




Figure 2.9: PP2B inhibition modulates calcium oscillation frequency.  A. Simulation of 
the model with increased feedback achieved when PP2B activity is decreased (shaded 
region). B. The effect of adding a PP2B inhibitor cyclosporine A (CsA) (3 μM) on 
calcium oscillations (n = 7). 
 
Figure 2.10: Simulations predict calcium oscillation frequency modulation. A. Effect of 
PKA activation and activity parameters on the frequency of oscillations, simulated by the 
simultaneous variation of a parameter relating to the extent of PKA phosphorylation of 
channels (kPKA,V) and a parameter controlling the maximal activity of PDE (kPDE). B. 
Effect of PKA activation and activity parameters on the amplitude of oscillations, 




2.2.5 Direct activation of PKA triggers the oscillatory circuit 
Beta cells are constantly subject to regulation by a broad range of distinct signals, 
including electrical, metabolic and hormonal signals (61, 62). Given the tunability of this 
signaling circuit and the capacity of its major components to connect to different signal-
sensing networks (80, 81), one of its important functions may be to integrate multiple input 
signals that can independently activate the circuit’s components. Thus, it is possible that 
various signals, via direct activation of different components, can trigger the oscillations 
of this signaling system. To test this hypothesis, 1–3 μM of 8-bromoadenosine-3′,5′-cyclic 
monophosphate-acetoxymethylester, a cAMP analog that preferentially activates PKA, 
was added to MIN6 cells expressing AKAR. In over 40% of the cells (n = 16), the addition 
of this cAMP analog alone triggered oscillatory changes in PKA activity (Figure 2.11), 
similar to the TEA-induced oscillations. Furthermore, different strengths of the input 
signals could apparently be encoded into different activity patterns, because higher doses 
(10–20 μM) of the same cAMP analog triggered a gradual increase in PKA activity with a 
small-amplitude higher-frequency oscillatory change superimposed on the monotonic 
activation rise (Figure 2.11A) (n = 13). Our mathematical model captured the basic 
characteristics of the oscillations induced by direct activation of PKA (Figure 2.11B) and 
suggested that sufficiently strong PKA feedback can initiate oscillations even when the 
feedback loop involving calcium and membrane potential is initially inactive. Furthermore, 
the distinct PKA activity patterns induced by low doses and high doses of cAMP (Figure 
2.11) showed an elaborate transition of behaviors that is indicative of the frequency change 
of the oscillatory circuit. Thus, PKA is an integral component of the oscillatory circuit and 
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is capable of not only tuning but also enabling the oscillatory circuit behaviors in response 
to specific input signals. 
 
Figure 2.11: Direct activation of PKA triggers the oscillation of the circuit.  A.  
Representative time courses showing different oscillatory PKA behaviors upon 
stimulation with low (1–3 μM) and high (10–20 μM) doses of a PKA-specific cAMP 
analog (n = 16 and 13, respectively). B. Simulation of the model showing the different 
oscillatory PKA activities upon stimulation with low and high levels of cAMP analog. 






2.2.6 Spatiotemporal controls via oscillatory PKA activity 
Each of the key components of the oscillatory circuit—calcium, cAMP and PKA—
regulates a diverse set of cellular functions with high specificity. In the case of PKA, spatial 
compartmentalization of PKA-dependent signaling has been identified as an important 
mechanism underlying specific regulation of distinct functions (57). We propose that the 
oscillatory PKA activity enabled by the calcium-cAMP-PKA circuit can serve as a distinct 
mechanism for achieving signaling diversity. 
At the level of temporal regulation, given an oscillatory PKA activity, both 
oscillatory and sustained phosphorylation of PKA substrates can be achieved, depending 
on the access of the substrate to phosphatases reversing PKA phosphorylation (Figure 
2.12). For example, recruitment of PKA and phosphatase PP2B to L-type calcium channels 
can ensure efficient and rapid phosphorylation and dephosphorylation within this signaling 
complex (79). Repetitive phosphorylation of the channels, which has been suggested in 
previous studies to be critical for proper beta cell function (82), would in turn ensure that 
the activity of the channel reaches certain threshold level only periodically; this pattern 
would decrease the probability of spontaneous channel openings between insulin secretion 
phases. In contrast, PKA targets devoid of high local phosphatase activity can integrate 






Figure 2.12: Simulation of effect of phosphatase activity on phosphorylation of generic 
target substrate, S. A. Low phosphatase activity. B. High phosphatase activity  
More exquisite spatial control of PKA activity may also be achieved via 
oscillations. For instance, cAMP-PKA signaling microdomains, such as those defined by 
AKAP-assembled signaling complexes, may also depend on the kinetics of signaling 
reactions and the presence of regulatory feedback interactions (44). A local PKA signaling 
complex is typically assembled by A-kinase anchoring protein (AKAP) binding to the 
regulatory (R) but not the catalytic (C) subunit of PKA. This signaling 
compartmentalization can be lost if the unanchored C-subunit diffuses away after 
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dissociation from the R-subunit, rather than being recaptured when cAMP dissociates from 
the R-subunits. It is thus paradoxical that local PKA activity can be maintained for 
prolonged periods of time. Our model suggests that, under the experimental conditions 
analyzed above, this apparent paradox can be resolved, as the oscillatory circuit is capable 
of maintaining a relatively low time-averaged PKA activity, while having relatively high 
maximal peak PKA activity (Figure 2.13; local activation regime). The low average PKA 
activity implies a low average free concentration of the C-subunit in the signaling domain 
and thus a low escape rate of the subunit from the domain. Recapture of the C-subunit can 
help reset the local PKA activity cycle. At the same time, the peak PKA activity can 
periodically exceed the threshold levels needed for full activation of the target substrates 
and would be further enhanced if the substrates have limited access to the corresponding 
phosphatases (Figure 2.13). On the other hand, an enhanced input into PKA activation and 
the resulting high average PKA activity could lead to increased escape of the C-subunit 
from a local signaling domain (Figure 2.13; global activation regime). At the subcellular 
organelle level, increased escape of the C-subunit from a cytosolic signaling compartment 
could result in the C-subunit’s translocation into the nucleus (Figure 2.14). We sought to 
experimentally validate this prediction. Indeed, we found that although low doses of a 
cAMP analog induced oscillations in the cytosol without affecting nuclear PKA activity or 
phosphorylation of an endogenous transcription factor CREB, the gradual increase in PKA 
activity with superimposed high-frequency oscillation induced by high doses of the analog 
led to an increase in nuclear PKA activity and CREB phosphorylation (Figure 2.13B-D). 
This effect on CREB phosphorylation was also observed with the cotreatment of CsA or 
IBMX with a low dose of the cAMP analog (Figure 2.15A) or with TEA (Figure 2.15B). 
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Thus, the oscillatory PKA activity can apparently encode context-dependent 
spatiotemporal information for controlling diverse output signals. 
 
Figure 2.13: Oscillatory PKA activity confers spatial control of substrates. A. Simulation 
of the model showing the indirect activities of local (normalized mean intracellular 
calcium oscillations) and global (using normalized mean active PKA concentration as a 
proxy) targets of PKA activation upon increase in the input adenylate cyclase activity 
and hence frequency of oscillations. The expected “local activation” regime, defined by 
the adenylate cyclase activity at which the difference between log(normalized mean PKA 
activity) and log(normalized peak PKA activity) is maximal, is shaded in orange. The 
area shaded in green is bounded by the nominal adenylate cyclase activity, reflecting the 
expected physiological scenario. B. Representative time courses of nuclear-localized 
AKAR (NLS-AKAR) showing the absence and presence of nuclear PKA activity upon 
stimulation with low (1–3 μM) and high (10–20 μM) doses of a PKA-specific cAMP 
analog, respectively (n = 7 and 4, respectively). C. Phospho-immunoblot analysis using 
antiphospho-CREB (pSer133) shows no changes in CREB phosphorylation upon 
stimulation with a low dose (LD) of the cAMP analog (2 μM), whereas increased 
phosphorylation of CREB is observed upon stimulation with a high dose (HD) of the 
same cAMP analog (10 μM) or 50 μM forskolin (FsK). D. Densitometric analysis of 
phosphorylated CREB (pSer133) (n = 3) normalized to CREB expression shows a 
significant difference between the levels of CREB phosphorylation stimulated by the low 




Figure 2.14: Schematic of spatial effects of PKA activity temporal dynamics. Under low 
frequency conditions, the mean PKA activity would be below a certain threshold for re-
capture and so catalytic subunits would be periodically released and captured. However, 
under high frequency conditions, the mean PKA activity may cross the threshold leading 
to continued release of catalytic subunits which may then diffuse to a different 




Figure 2.15: CREB activation in response to PP2B and PDE inhibition. Phospho-
immunoblot analysis of CREB phosphorylation (pS133) in response to a low dose (LD) of 
the cAMP analog (2 μM), in the absence or presence of CsA (3 μM) or IBMX (100 μM), 
with densitometric analysis. 
2.3 Discussion 
Oscillation of signaling activity can be a versatile mechanism for achieving 
diversity and specificity. This notion was first demonstrated in the case of calcium 
oscillation, the frequencies of which are determined by the amount and type of extracellular 
signals (83-85) and can influence the efficiency and specificity of gene expression (86, 87). 
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Our analysis suggests that, as in the case of calcium oscillations, the frequency of PKA 
activity oscillation can be used as a signaling currency, integrating input signals according 
to their identities and doses and generating specific functional output (for example, local 
versus global signaling modes). In this way, the oscillatory PKA activity allows PKA to 
function as a versatile signaling transducer that can exert spatiotemporal controls over a 
variety of functional outcomes in response to specific signals. Future studies will directly 
evaluate the effects of changing the PKA oscillation frequency on cellular processes that 
are important to beta cell functions, such as gene expression and insulin secretion. 
Our analysis further demonstrates that, in addition to transducing signals via 
activity oscillation, PKA in insulin-secreting cells also plays an active role in shaping the 
oscillatory patterns of other key components in the signaling circuit, such as calcium. This 
finding is in contrast to previous studies in which oscillations of several protein kinases 
(for example, PKA (88), PKC (21), mitogen-activated protein kinases (89, 90) and 
calmodulin-dependent protein kinase II (91)) were demonstrated, but the potential role of 
these kinases in shaping the oscillation patterns was not explored. It remains to be seen 
whether some of these kinases or other candidate kinases are also focal points of oscillatory 
activities. 
Given that each of the key components in the calcium-cAMP-PKA circuit can 
regulate distinct functions, the synchronized oscillations ensure the coordinated activity of 
these key players, providing a mechanism for achieving efficient and specific control of 
cellular processes. Therefore, it is reasonable to suggest that complex cellular behaviors 
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may critically depend on such synchronization and coordination of various signaling 
molecules. 
In summary, this current study provides a clear example of exquisite temporal 
control of a protein kinase within an oscillatory circuit. This signaling system could serve 
as a paradigm for understanding the spatiotemporal regulation of other signaling networks 
that control complex cellular processes. Furthermore, given the ubiquitous presence of the 
key components of the oscillatory calcium-cAMP-PKA circuit (92, 93), its effects are 
likely to be widespread, serving to regulate diverse processes in various cell types. 
2.4 Computational model development 
2.4.1 Introduction  
Multiple signalling mechanisms are known to employ the second messenger 
calcium, with variable intracellular calcium levels ([Ca2+]i) used by divergent signalling 
cascades to elicit different responses, primarily mediated through protein kinases (94). The 
mathematical model for describing calcium oscillations in the pancreatic beta-cell system 
proposed here is built in a modular fashion, consistent with previous models, integrating 
them and incorporating new features. Particularly of note here is the role of PKA mediated 
feedback which serves to aid in calcium oscillations. The model is described below. First, 
we put it in the context of two related modeling studies.   
Fridlyand et al. (95) described a model of calcium-cAMP oscillations in MIN6 
cells, demonstrating in particular that the oscillations of cAMP linked to [Ca2+]i changes 
due to glucose stimulation are anti-phasic. The calcium kinetics in this model are described 
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by calcium fluxes across the plasma membrane and ER membrane. The synthesis and 
degradation of cAMP are governed by the activities of calcium-calmodulin (CaM)-
dependent Adenylate Cyclases (ACs) and Phosphodiesterases (PDEs) such as AC8 and 
PDE1C respectively. Simulations showed that a phase delay between calcium and cAMP 
oscillations could occur if CaM-dependent PDE activity was present but CaM-dependent 
AC activity was low. Increasing the CaM-dependent AC activity however resulted in 
calcium and cAMP oscillations that were in phase with each other. Consistent with this 
study, our own model topology analysis (see Section 2.4.3 below), and our experimental 
observations, the signaling circuit in our model involves calcium-activated PDE which 
leads to anti-phasic oscillations of calcium and cAMP. Overall, this model is focused on 
how the oscillations in cAMP may be ‘enslaved’ to calcium oscillations, without directly 
considering possible feedback from cAMP through Protein Kinase A (PKA), as considered 
in our model.   Indeed, calcium levels in the pancreatic beta-cells have been shown to be 
modulated by cAMP-dependent mechanisms (96, 97). This likely occurs through direct or 
indirect modulation of channel conductances by a cAMP-dependent process. Simulations 
in the model by Fridlyand et al. illustrated this point by showing that calcium oscillations 
were affected when conductances of channels were varied directly. In contrast, our model 
incorporates an explicit feedback loop via PKA, in accordance with our experimental data, 
and focuses on the role of this feedback loop and its importance in defining the signal 
properties of this circuit.  
The feedback from cAMP to calcium regulation has been modelled previously in 
Aplysia neurons by Gorbunova and Spitzer (98). The Gorbunova-Spitzer model comprises 
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3 states describing the kinetics of calcium, IP3R and cAMP. Calcium oscillations are 
generated by the interplay between calcium and IP3R in this model, which is based on a 
previous model by Tang and Othmer (99). Our model incorporates this interplay, while 
also detailing the contributions of potassium (K+) and calcium currents across the plasma 
membrane in generating calcium oscillations. More importantly, the Gorbunova-Spitzer 
model describes the calcium dependence on cAMP using CaM dependent AC and the 
cAMP feedback on calcium in terms of cAMP levels directly. On the other hand, our model 
aims to expand on the role of this feedback by employing the dynamics of PKA activation 
and the subsequent phosphorylation of Voltage Dependent Calcium Channels (VDCCs) 
and Inositol trisphosphate Receptors (IP3Rs) by activated PKA. The basic circuitry of the 
components involved in this system and the different modules that make up this model are 
summarized in Figure 2.21. 
In summary, the calcium oscillations in the pancreatic beta-cell system are modeled 
here to describe the interplay of membrane voltage (Vm), calcium, cAMP and PKA, each 
of which is developed and described as a semi-autonomous modeling module (Figure 
2.21). The signal transduction cascade is initiated by depolarization of the plasma 
membrane (carried out experimentally by using K+ channel blockers, such as TEA), which 
causes the opening of VDCCs resulting in an influx of calcium. An increase in intracellular 
calcium results in activation of CaM, which can modulate the activities of both AC and 
PDE. Consistent with the model presented here and previous findings by Fridlyand et al. 
(95), as mentioned before, we experimentally observed that calcium and cAMP follow an 
anti-phasic relationship which would necessitate the involvement of calcium inhibited ACs 
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and/or calcium activated PDEs. The binding of the second messenger, cAMP, to the 
regulatory subunits of PKA (R2) releases the catalytic subunits (C2), which in turn 
phosphorylate the VDCCs and IP3Rs that lead to a calcium influx and open up the internal 
calcium stores respectively, thereby setting up a negative feedback loop. 
2.4.2 Voltage and Calcium modules of the model 
The voltage module (Figure 2.21), comprising equations (1-9) below, describes the 
membrane potential dynamics and is based on the original set of equations employed in the 
Chay-Keizer model (100) and derived from a later version of the Chay-Keizer model 
detailed by Sherman, Li and Keizer (101). The values of the parameters for this and other 
model modules are detailed in Table 2.1. When the parameters present in the original model 
were used, we observed that the frequency of oscillations was much lower than the 
frequency of oscillations experimentally observed. Hence, some of the values were 
modified in order to corroborate the experimental data. Specifically, the conductance of 
VDCCs was reduced to 600 pS, as was similarly done in the model published by Fridlyand 
et al. (95) where the nominal value for VDCC conductance was chosen to be 670 pS. To 
match the change in VDCC activity owing to this reduced conductance and to match the 
experimentally observed frequency of oscillations, the conductance of the delayed rectifier 
K+ channels also was reduced to 260 pS. We note that the conductance values are a function 
of the number of available channels, and can reflect the cell type-specific properties of the 
cells used in experiments. The value of the parameter fi was chosen by Chay and Keizer on 
the basis of the timescale of the oscillations in their model, in the absence of any concrete 
experimental measurements for free calcium in pancreatic beta-cells. Since the frequency 
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of oscillations experimentally observed in our system was much lower than that in the study 
by Chay and Keizer, fi was reduced accordingly to 1×10-4. Apart from these frequency 
related parameters, the reversal potential for VDCCs, ECa was modified to 100 mV, since 
previous reports have consistently used this value (100, 102). The equations describing the 
voltage module are detailed below. The symbols have their usual meanings as described in 
Table 2.1, Table 2.2 and Table 2.3. 
2.4.2.1 Voltage Module 
 
𝑚∞ = 0.5 (1 + tanh (
𝑉−𝑣1
𝑣2
))        ...1 
𝑤∞ =  0.5 (1 + tanh (
𝑉−𝑣3
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𝐼𝐾 = 𝑔𝐾𝑤(𝑉 − 𝐸𝐾)         ...4 
𝐼𝐶𝑎 = 𝑔𝑐𝑎𝑚∞(𝑉 − 𝐸𝐶𝑎)        ...5 
𝐼𝐿 = 𝑔𝐿(𝑉 − 𝐸𝐿)         ...6 
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2.4.2.2 Calcium module 
 
The calcium current through the VDCCs, and leak through other channels 
contribute to the calcium flux across the plasma membrane. For our initial model topology 
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analysis (see 2.4.3 below), we considered only the plasma membrane flux for the sake of 
simplicity and so described calcium dynamics as follows: 
𝑗𝐶𝑎,𝑉 = 𝑓𝑖(−𝛼𝐼𝐶𝑎 − 𝑣𝐿,𝑃𝑀[𝐶𝑎
2+]𝑖)       ... 10 
2.4.3 Model Topology Analysis 
2.4.3.1 Model Development 
 
The main purpose of the modeling analysis in the present study was to develop a 
minimal yet sufficiently detailed model accounting for and constrained by the 
experimented observations, also presented here. The number of the molecular species 
considered and the accumulated prior research of possible chemical links between these 
species introduces considerable complexity into the initial model development, and 
potential for making it hard to manage and constrain sufficiently. We therefore initially 
considered several possible simplified versions of how the calcium and cAMP modules 
might interlink, in terms of their consistency with experimental data. Specifically, we 
focused on the experimental observations that calcium and cAMP oscillations are anti-
phasic, suggesting the involvement of calcium-inhibited ACs and/or calcium-activated 
PDEs. We therefore explored different possible combinations in which the components of 




Figure 2.16: Possible topologies for the circuit with the components shown. Solid lines 
indicate fixed connections. Dotted lines indicate variable connections. The numbers -1, 0 
and 1 indicate if the link is inhibitory, absent or activating respectively. 
ACs can be activated by calcium-calmodulin (CaM.Ca4) or inhibited by calcium. 
PDEs could also be CaM.Ca4 dependent. The calcium-AC link may be present according 
to 2 possibilities – inactivation or no dependence – represented as -1 or 0. Similarly, ACs 
may or may not be activated by CaM.Ca4 which is represented by 0 or 1. PDEs can be 
activated or inactivated by CaM.Ca4 or can be independent of CaM.Ca4 activity. So, this 
link can be represented as 1, -1 or 0, respectively. Accordingly, we have 2x2x3 = 12 
possible circuits.  
At this point, we chose to develop a heuristic model for cAMP and PKA kinetics 
incorporating these dependencies. Our experimental data shows a strong correlation 
between PKA and calcium dynamics with an increase in intracellular calcium following an 






[0,1] [-1,0,1] [-1,0] 
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by PKA likely through phosphorylation of calcium channels. We represent this PKA-
calcium dependence as follows: 
𝑥𝑃𝐾𝐴 = (1 + 𝐾𝑃𝐾𝐴𝐶𝑎[𝑃𝐾𝐴
∗])          …11 
Therefore, the calcium flux can be modified as: 
𝑑𝐶𝑎
𝑑𝑡
= 𝑗𝐶𝑎,𝑉 . 𝑥𝑃𝐾𝐴            …12 
To model the dependence of ACs and PDEs on calcium-calmodulin (CaM.Ca4), we 
assumed quick equilibration of calcium to calmodulin binding, and thus existence of quasi-
steady-state levels of CaM.Ca4,  the concentration of which therefore is proportional to the 
concentration of calcium raised to the index of 4 (due to 4 Calcium binding sites). The 
factors describing these modulations are shown in equations 13 and 14. In these equations, 
KCacAMP and KCaMcAMP are appropriate constants controlling these processes. While, in 
reality, the extent of Calmodulin mediated modulation of AC and PDE could be different, 
the goal of this preliminary model was to try to capture the essence of the experimental 
data qualitatively. Hence, we used the same xCaM factor for both AC and PDE modulation. 
𝑥𝐶𝑎 = (𝐾𝐶𝑎𝑐𝐴𝑀𝑃 + [𝐶𝑎
2+]𝑖)        … 13 
𝑥𝐶𝑎𝑀 = (𝐾𝐶𝑎𝑀𝑐𝐴𝑀𝑃 + [𝐶𝑎
2+]𝑖
4)       … 14 
The cAMP dynamics can therefore be described as: 
𝑑[𝑐𝐴𝑀𝑃]
𝑑𝑡
= 𝑘𝑓,𝐶𝑎𝑐𝐴𝑀𝑃 . 𝑥𝐶𝑎
𝑔𝐶𝑎𝑐𝐴𝑀𝑃 + 𝑘𝑓,𝐶𝑎𝑀𝑐𝐴𝑀𝑃 . 𝑥𝐶𝑎𝑀
𝑔𝐶𝑎𝑀𝑐𝐴𝑀𝑃 − 𝑘𝑑,𝑐𝐴𝑀𝑃 . 𝑥𝐶𝑎𝑀
ℎ𝑐𝐴𝑀𝑃 . [𝑐𝐴𝑀𝑃] …15 
The indices gCacAMP, gCaMcAMP, hcAMP reflect the presence or absence of the 
respective link in the chosen topology. For instance, in a circuit where AC is inhibited by 
calcium, not dependent on CaM, and PDE is activated by CaM, the appropriate indices 
would -1, 0 and 1, respectively. 
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Finally, the kinetics of PKA can be described by equation 16 below. The PKA 
homodimer consisting of 2 regulatory subunits (R2) and 2 catalytic subunits (C2) binds to 





∗]      … 16 
Since, this is a representative model we initially assume that certain binding 
constants and the parameters pertaining to cAMP and PKA kinetics (KPKACa, KCacAMP, 
KCaMcAMP, kf,CacAMP, kf,CaMcAMP, kd,cAMP, kf,PKA, kd,PKA) have an arbitrary equal value of 0.5. 
To explore the sensitivity of the model to parameter variation, we varied 4 parameters 
defined below: 
𝐾𝑃𝐾𝐴𝑣𝑎𝑟 = log10 (
𝐾𝑃𝐾𝐴𝐶𝑎
𝐾𝑃𝐾𝐴𝐶𝑎
𝑜 ) 𝑤ℎ𝑒𝑟𝑒 𝐾𝑃𝐾𝐴𝐶𝑎
𝑜 = 0.5  𝜇𝑀−1 




𝜆𝑐 = log2 (
𝑘𝑓,𝑐𝐴𝑀𝑃
𝑘𝑑,𝑐𝐴𝑀𝑃
) , 𝑤ℎ𝑒𝑟𝑒 𝑘𝑓,𝐶𝑎𝑐𝐴𝑀𝑃 = 𝑘𝑓,𝐶𝑎𝑀𝑐𝐴𝑀𝑃 = 𝑘𝑓,𝑐𝐴𝑀𝑃(𝑠𝑎𝑦) 




In each of the studied model variations, one of the chosen parameters is varied, 
while keeping the rest constant, thus yielding responses for all the 12 possible circuits. 
Based on experimental results, we further identified criteria that appropriate model 
topology should be able to satisfy: 
1. The calcium and cAMP oscillations are anti-phasic. 




To quantify the phase delay between the calcium and cAMP oscillations, we 
analysed the circular cross-correlation function (C) as a function of time of oscillations. If 
the oscillations are in phase, the maximum of C occurs at zero time lag. If the oscillations 
are out of phase, the maximum occurs at lags equalling multiples of the time period of the 
oscillation. We use the following metric to quantify the time delay: 
𝑇𝑖𝑚𝑒 𝑑𝑒𝑙𝑎𝑦 𝑚𝑒𝑡𝑟𝑖𝑐 =
𝐶(𝑧𝑒𝑟𝑜 𝑙𝑎𝑔)−𝑚𝑎𝑥(𝐶)
𝑚𝑖𝑛(𝐶)−𝑚𝑎𝑥(𝐶)
      … 17 
Therefore, for oscillations that are in-phase, we would have C(zero lag) near the 
maximum and so the metric has a small value. On the other hand, anti-phasic oscillations 
would result in larger metric values. To quantify the “sharpness” of the calcium rise and 
cAMP decay phases, we determined the t1/2 of the respective phases as follows: 
𝐶𝑎𝑅𝑖𝑠𝑒 = 𝑚𝑒𝑎𝑛 (𝑡𝐴
2
− 𝑡𝑇𝑟𝑜𝑢𝑔ℎ)       … 18 
where tA/2 is the time at which the calcium concentration level is half of its amplitude and 
tTrough is the time at which the trough corresponding to a certain rise phase occurs. This t1/2 
is measured over multiple cycles and the mean is obtained. 
Similarly, the cAMP decay phase is quantified as below: 
𝑐𝐴𝑀𝑃𝐷𝑒𝑐𝑎𝑦 = 𝑚𝑒𝑎𝑛 (𝑡𝑃𝑒𝑎𝑘 − 𝑡𝐴
2
)       … 19 
where, tPeak is the time at which the peak occurs and tA/2 is as defined above. 
In each of the following simulations, where multiple circuits with different 
parameters are simultaneously compared, CaRise and cAMPDecay are normalized with 
respect to their corresponding maxima. Finally, a metric to quantify the coincidence of 









)    … 20 
2.4.3.2 Simulations 
 
As described above, 4 parameters were varied to describe different possible circuits. 
In each such exercise, 3 different values for the parameter were chosen – represented by 
the set {-1,0,1} – a “low” value, a nominal value or a “high” value. The parameter value 
changes across the rows in the plots presented below (Figure 2.17-Figure 2.20). Therefore, 
each row corresponds to the full set of 12 circuits at a fixed parameter value. Conversely, 
each column corresponds to a particular circuit with the parameter value spanning the 
complete range. In the plots, the ‘warmer’ (red being the warmest) colours indicate a higher 
value for the corresponding metric and ‘cooler’ (blue being the coolest) colours correspond 
to lower values. White patches indicate that the corresponding circuits did not produce 
oscillations or produced complex oscillations with varying amplitude, a feature that we do 
not observe in our experimental results. The ordered set of numbers in the plots should be 
read as: [parameter value, Ca-AC link, CaM-AC link, CaM-PDE link]. As already 
mentioned, we looked for circuits that satisfied certain key criteria in accordance with our 
experimental results. So, we identified circuits that could produce anti-phasic oscillations 
(which correspond to warmer patches in the Time Delay Metric plots) and which had a 
simultaneously fast calcium rise phase and cAMP decay phase (which correspond to cooler 




Figure 2.17: Topology analysis with changes in PKA feedback parameter. Changes in the 
time delay between Calcium and cAMP oscillations (top panel) and the coincidence of 
rapid calcium rise phase and a rapid cAMP decay phase (bottom panel) due to change in 
KPKAvar. KPKAvar takes one of the values {-1,0,1}. 
First, we varied the parameter that relates to the PKA feedback to calcium. There 
appear to be 5 circuits that can produce anti-phasic oscillations and with sharp calcium rise 
and cAMP decay phases as shown by the black oval outlines in Figure 2.17. We also 
considered circuits with “yellow” patches in the 3rd row, because they have a shorter rise 




Figure 2.18: Topology analysis with changes in calcium and CaM binding parameters. 
Changes in the time delay between calcium and cAMP oscillations (top panel) and the 
coincidence of rapid calcium rise phase and a rapid cAMP decay phase (bottom panel) 
due to change in .  takes takes one of the values {-1,0,1}. 
We next examined the ratio of the parameters relating to calcium binding and CaM 
binding to the target protein (Figure 2.18). Again, we obtained 5 circuits that satisfied the 
required conditions. Three of them appeared to be robust in satisfying the criteria despite a 




Figure 2.19: Topology analysis with changes in cAMP generation and degradation 
parameters. Changes in the time delay between calcium and cAMP oscillations (top 
panel) and the coincidence of rapid calcium rise phase and a rapid cAMP decay phase 
(bottom panel) due to change in c. c takes one of the values {-1,0,1}.  
We next analyzed the ratio of the formation and degradation constants pertaining 
to cAMP dynamics (Figure 2.19). For the sake of convenience, we assumed the rate 
constant for formation to be same for both calcium dependent and CaM dependent ACs. 
This parameter was varied two-fold. A higher fold increase in the value of this parameter 
produced very high frequency oscillations with varying amplitude, a feature not consistent 
with our experimental results. Again, the same 5 circuits as in Figure 2.19 were found to 




Figure 2.20: Topology analysis with changes in PKA formation and degradation 
parameters. Changes in the time delay between Calcium and cAMP oscillations (top 
panel) and the coincidence of rapid Calcium rise phase and a rapid cAMP decay phase 
(bottom panel) due to change in p. p takes one of the values {-1,0,1}. 
We next studied the effect of the ratio of formation and degradation constants 
relating to PKA dynamics (Figure 2.20). As in Figure 2.19, we identified 3 relatively robust 
circuits of 5 possible candidates. Based on the above analyses, we identified the 5 following 
circuits that repeatedly satisfied the required criteria: (-1,1,1), (-1,0,0), (-1,0,1), (0,1,1) and 
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(0,0,1). Of these, the 3 following circuits appeared to be relatively robust to parameter 
variation in each case: (-1,1,1), (-1,0,1) and (0,0,1). 
In all of the 3 circuits mentioned above, we found a common feature, namely that 
the 3rd number in the set is always 1. In other words, PDE activation by CaM is sufficient 
to produce Calcium and cAMP oscillations out of phase with each other, with Calcium 
having a sharp rise and cAMP having a sharp decay phase. We used this result in 
formulating our model for the Calcium-cAMP-PKA circuit as detailed in the following 
sections. 
2.4.4 A Detailed Model of the Calcium-cAMP-PKA Signaling Circuit 
Based on the results obtained by exploring different circuit combinations as 
described in Section 2.4.3, we identified the minimal topology that could explain our 
experimental results, as shown in Figure 2.21 below. Accordingly, we developed a 
mechanistic model for the calcium, cAMP and PKA modules for this circuit as detailed 
below. The Voltage module as mentioned previously is based on the Chay-Keizer model 
and was retained with the same modifications that were used in the model topology analysis 
detailed in Section 2.4.3. On the other hand, we developed a more comprehensive and 
mechanistic model to describe the dynamics of calcium, cAMP and PKA as is described in 





Figure 2.21: Circuitry of main molecular ‘players’ in the system. Note the two feedback 
circuits involving Vm and calcium, and calcium-cAMP-PKA. The latter is highlighted by 
thicker arrows. The different modules are represented by different colours per the legend 
shown on the right. VDCC, Voltage-Dependent Calcium Channel; Vm, Membrane 
potential; AC, Adenylate Cyclase; PDE, Phosphodiesterase; PKA, Protein Kinase A; R, 
Regulatory subunit of PKA; C, Catalytic subunit of PKA; ER, Endoplasmic Reticulum; 
cAMP, Cyclic adenosine monophosphate; Kv channel; Voltage-gated  K+ channel; KCa 




• Equations 1-9 
Voltage module
• Sections 2.4.2.2 and 2.4.4.1










2.4.4.1 A more detailed model of the Calcium module 
 
Apart from Calcium influx across the plasma membrane detailed in equation 10, 
calcium release from the internal stores is also assumed to play a major role in many 
processes that involve calcium oscillations, as evidenced by the glucose regulated 
expression of IP3Rs in rat pancreatic islets (103). Hence, equations were set up to describe 
the net calcium release from and uptake by internal stores mediated by IP3Rs and Smooth 
Endoplasmic Reticulum Calcium ATPases (SERCAs) respectively.  
The driving force for the IP3R mediated flux was described in terms of the calcium 
gradient across the ER. The opening probability of IP3R was modelled as a bell-shaped 
function of [Ca2+]i (equation 21) based on previous work (104-106). Further, IP3Rs have 
been shown to be regulated by phosphorylation by PKA (107, 108) as can also be deduced 
from our experimental results that indicate the presence of a PKA mediated feedback 
(which may occur via phosphorylation of channels that contribute to an increase in 
intracellular calcium levels). Hence, the effect of PKA on the flux through IP3R was 
incorporated by including a linear dependence on PKA, as shown below: 










2) ... 21 
where, A = (Ka + Ki)/(KaKi), B = (1/KaKi) . 
∴ 𝜙𝐼𝑃3𝑅 = 𝑃𝑜𝑝𝑒𝑛. (𝐶. [𝑃𝐾𝐴
∗]). ([𝐶𝑎2+]𝑠𝑡𝑜𝑟𝑒𝑠 − [𝐶𝑎
2+]𝑖)    ... 22 
To estimate the parameters governing the opening probability of the IP3R channel, 
previous models describing the IP3R gating of these channels were considered. While these 
models do not explicitly describe the mechanisms accounting for the bell-shaped curve 
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mentioned above, it is possible to derive the appropriate parameters by making certain 
assumptions and modifications as described below: 
According to the Gorbunova-Spitzer Model (98), which is in turn based on a model 



























       ... 24 
where the Calcium fluxes in 23 are described in terms of the Voltage driven channels (1st 
term), IP3R mediated Calcium release (2nd term) and SERCA mediated Calcium uptake 
from the cytosol (3rd term). 
For the sake of convenience, we assume in our model that the IP3R is at a quasi 
steady state. Therefore, the equation 24 modifies to: 









       ... 25 






























From (22) and (26) we obtain: 
𝑃𝑜𝑝𝑒𝑛. (𝐶. [𝑃𝐾𝐴
∗]). ([𝐶𝑎2+]𝑠𝑡𝑜𝑟𝑒𝑠 − [𝐶𝑎











)  ... 27 












         ... 30 
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Hence, from the Gorbunova-Spitzer model, one can estimate: A = 2.869 M-1, B = 
28.69 M-2. Estimation of the parameter C, however, requires a complex iterative 
procedure, since it depends on [PKA*], which in turn again depends on the above equations. 
Therefore, for the sake of convenience and to roughly estimate characteristic, order of 
magnitude value of this parameter, we assumed PKA* to be in quasi steady state, in which 
case, one obtains the following relation as was shown by Gorbunova and Spitzer (refer to 
the Supplementary file accompanying the paper by Gorbunova and Spitzer (98) for more 
details): 
[𝑃𝐾𝐴∗] = 𝑘𝑃𝐾𝐴−𝑐𝐴𝑀𝑃[𝑐𝐴𝑀𝑃]
2       ... 31 
where, kPKA-cAMP = 2 M-1. Estimating an average cAMP concentration of about 0.3 M, 
we get C = 2.133 M-1. 
Finally, the SERCA activity was modeled as a function of [Ca2+]i with a Hill’s 
coefficient of 2, as was done by Gorbunova and Spitzer, and by Tang and Othmer.  
Hence, the final equation for the calcium flux through the internal stores can be 
represented as: 















2) ... 32 
It should be noted that, while the equations of the voltage module employ 
parameters that are specifically suited for the pancreatic beta-cell system, the equations for 
flux across the internal stores employed by Gorbunova and Spitzer, and by Tang and 
Othmer were used in the context of Aplysia neurons and cardiac myocytes respectively. 
Hence, using the equations with the values derived above might lead to oscillations with 
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frequencies different from that observed in our experiments. In reality, parameters like 
IP3R density, for instance, that govern flux through internal stores would be expected to 
differ when used in the pancreatic beta-cell system. We are unaware of any measurements 
of the number or density of IP3Rs in these or other cell types. Nevertheless, the IP3R 
density on the pancreatic beta-cell ER would be expected to be quite different from that in 
other systems which necessitates the inclusion of another parameter, kIP3R. The presence of 
this parameter is, in fact, necessary for the matching of experimental results and model 
simulations. Similarly, the parameters pertaining to SERCA activity were also refined so 
as to ensure robust oscillations of frequencies matching those in the initial experimental 
results. This process is a part of model ‘training’. The trained model was then used to make 
further predictions as detailed earlier. 
The values for the parameters were therefore, chosen in accordance with our 
experimental data: A = 0.2869 M-1, B = 2.869 M -1, C = 0.2133 M -1, kIP3R = 0.05, Vs 
= 0.1 M.s-1, Ks = 10 M. 
The net calcium flux is the sum of calcium influx through the plasma membrane 
and calcium release by internal stores. As mentioned before, PKA phosphorylation of 
various channels that contributes to influx of calcium is most likely the manner of PKA 
mediated feedback that is indicated by our results. Hence, the PKA dependence of calcium 
flux across the plasma membrane was also incorporated semi-mechanistically. The net 




= 𝑗𝐶𝑎,𝑉(1 + 𝑘𝑃𝐾𝐴,𝑉[𝑃𝐾𝐴
∗]) + 𝑗𝐶𝑎,𝐼      ... 33 
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2.4.5 cAMP Module: 
A study by Leech et al. (109) indicated that adenylyl cyclases AC5 and AC6 were 
the predominant isoforms in human islets and rat islets, and in INS-1 and HIT-T15 cell 
lines. A study by Landa et al. (110) also indicated that AC5 and AC6 were present in MIN6 
cells, the cells that constitute our experimental model. Both AC5 and AC6 are believed to 
be calcium-inhibitable isoforms (111, 112). 





         ... 34 
Guillou, Nakata and Cooper (113) have previously analysed the kinetics of the AC6 
isoform which served as the basis for the kinetic description of AC in our system. Although 
AC5 and AC6 may be the predominant isoforms, it is currently unknown which isoform(s) 
may be active in the calcium-cAMP-PKA circuit. Hence, we assumed the minimal model 
configuration that could corroborate our data. As shown in the Model Topology Analysis 
(Section 2.4.3), the key features of our experimental data could be replicated even with a 
Calcium and Calmodulin independent AC in the presence of Calmodulin activated PDEs. 
Accordingly, we modified the kinetics detailed by Guillou et al. to describe constant AC 
activity as explained below. 
The value for Ki was estimated to be about 0.2 M by Guillou et al. The maximal 




From Figure 1 of the study mentioned above (113), the AC activity (per unit mass of the 
reaction volume) was estimated to be about 100 pmol.(min.mg)-1. Further, the reaction 
volume was 100 L and total protein content was about 0.5-2.5 mg/mL (as mentioned in 
the Methods section of the study by Guillou et al. (113)).  
Assuming a fairly purified AC fraction, the AC concentration was taken to be 
approximately 1 mg/mL; then the total AC activity present in 100 L of reaction volume 
(and hence, 100 g of protein) can be expressed of the form: 
100×10-12 mol ×100 g/(60 s × 1 mg) = 0.167 pmol.s-1. 
Hence, the activity (per unit volume of reaction volume) can be written as: 
0.167 pmol.s-1/100 L = 1.67 × 10-3 uM.s-1 ~ 0.002 M.s-1. 
Therefore, the maximal activity (or VAC,m) is of the order of 2×10-3 M.s-1. Assuming the 
mean [Ca2+]i concentration of about 1 M, one can estimate the order of the magnitude of 





≅ 𝑉𝐴𝐶,𝑚        ... 35 
Therefore, jAC is approximately equal to 0.002 M.s-1. 
To derive the parameters for modelling the action of PDE, the kinetics described 
by Bhalla and Iyengar (114) were used. The PDE activity is believed to be dependent on 
Calmodulin molecules bound to 3 Ca2+ ions (CaM.Ca3) and 4 Ca2+ ions (CaM.Ca4). 
Additionally, it is also assumed that cAMP is degraded by Calcium-independent PDEs.  
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 Referring to reaction C16 in Constants and Database of References section in the 
Supplementary material of the study by Bhalla and Iyengar (114), the kinetics of the 
activated form of PDE can be written as: 
𝑑[𝐶𝑎𝑀.𝐶𝑎𝑛.𝑃𝐷𝐸]
𝑑𝑡
= 𝑘16[𝐶𝑎𝑀. 𝐶𝑎𝑛]. [𝑃𝐷𝐸] −  𝑘−16[𝐶𝑎𝑀. 𝐶𝑎𝑛. 𝑃𝐷𝐸]   ... 36 
As mentioned above, both CaM.Ca3 and CaM.Ca4 are believed to modulate PDE 
activity. Although reaction C16 mentioned in the Supplementary of the study by Bhalla 
and Iyengar deals with CaM.Ca4, it is assumed here that the kinetics of the formation of 
the CaM.Ca4 and CaM.Ca3 complexes would not be drastically different. Hence, in the 
above equation ‘n’ would be either 3 or 4 depending on the complex being considered. 


















  ... 37 
where, [CaMtot] = 20 µM, n = 3 or 4, k1=7.5 µM, k2=2.7 µM, k3=31 µM and k4=31 µM. 
These parameter values are based on a study by Huang et al(115). 
Assuming [Ca2+]i is about 1 µM, the following approximation can be made, when 
n = 3 or 4: 
[𝐶𝑎𝑀. 𝐶𝑎𝑛] ≅ 𝑎𝑐(𝑛)[𝐶𝑎
2+]𝑖
𝑛
       







0.001 𝑓𝑜𝑟 𝑛 = 4
0.03 𝑓𝑜𝑟 𝑛 = 3
}       ... 39 
Since, both CaM.Ca3 and CaM.Ca4 are believed to play a major role in PDE kinetics 
(116), the cAMP kinetics was derived accordingly for both the complexes from the kinetics 
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detailed in reaction C18 in the Constants and Database of References section in the 








[𝑃𝐷𝐸∗]      ... 40 
Assuming that the PDE* complex is at steady state, equation (36) would lead to: 
[𝑃𝐷𝐸∗] = [𝑃𝐷𝐸𝑡]. (
𝑘16
𝑘−16
)[𝐶𝑎𝑀. 𝐶𝑎𝑛]      ... 41 











) [𝑃𝐷𝐸𝑡]. 𝑎𝑐(𝑛). [𝐶𝑎]
𝑛 = 𝐾𝑛,𝑐[𝐶𝑎]
𝑛[𝑐𝐴𝑀𝑃] ... 42 
The above modification is possible since, the usually assumed [cAMP] is much smaller 
than K18PDE. 
Using these values, we get K3,c = 0.072 µM-4.s-1 and K4,c = 2.16 µM-3.s-1 




4)[𝑐𝐴𝑀𝑃]     ... 43 
The synthesis of cAMP by AC, degradation by inhibitory and calcium independent PDEs 





≅ 𝑉𝐴𝐶,𝑚        ... 35 




4)[𝑐𝐴𝑀𝑃]     ... 43 
𝑗𝑃𝐷𝐸,𝑖𝑛𝑑 = 𝑘𝑑[𝑐𝐴𝑀𝑃]         ... 44 
𝑑[𝑐𝐴𝑀𝑃]
𝑑𝑡
= 𝑗𝐴𝐶 − 𝑘𝑃𝐷𝐸(𝑗𝑃𝐷𝐸 + 𝑗𝑃𝐷𝐸,𝑖𝑛𝑑)      ... 45 
The parameter kd for Calcium independent active fraction of PDE was assumed to be about 
0.01 s-1, as has been done by Fridlyand et al. 
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2.4.6 PKA Module: 
To model PKA dynamics, we take into account the fact that it exists as a homodimer 
of its regulatory and catalytic subunits (R2C2). Upon binding of 4 molecules of cAMP to 
the regulatory subunits in serial fashion, the protein releases its catalytic subunits one-by-
one. The reaction set J in the Constants and Database of References section in the 
Supplementary material of the study by Bhalla and Iyengar was used to model PKA 
dynamics. For the sake of convenience, it was assumed that the cAMP binding kinetics is 
relatively faster than the dissociation of catalytic subunit from the PKA complex. Consider, 
therefore, the kinetics when the ‘ith’ molecule of cAMP (c) binds to the PKA dimer (R2C2) 
bound to ‘(i-1)’ molecules of cAMP, which may be represented as below: 
        kif, kib 
ci-1R2C2 + c ↔ ciR2C2 
Assuming the cAMP-PKA complexes are at quasi steady state, we get: 
𝑑[𝑐𝑖𝑅2𝐶2]
𝑑𝑡
= 𝑘𝑖𝑓[𝑐][𝑐𝑖−1𝑅2𝐶2] −  𝑘𝑖𝑏[𝑐𝑖𝑅2𝐶2] = 0     ... 46 
∴ [𝑐𝑖𝑅2𝐶2] = (𝑘𝑖𝑓/𝑘𝑖𝑏)[𝑐][𝑐𝑖−1𝑅2𝐶2]      
 ... 47 
In the above equations, ‘c’ is cAMP, R2C2 is the PKA homodimer and ciR2C2 is the 
PKA homodimer bound to ‘i’ molecules of cAMP. Hence, we obtain: 
[𝑐4𝑅2𝐶2] = 𝐾1𝐾2𝐾3𝐾4[𝑐𝐴𝑀𝑃]
4[𝑅2𝐶2]      ... 48 
Hence, Ki = kif/kib (i = 1,2,3 or 4) in the equation (48). 
Now, we consider the mass balances in this system. In a general case, where a complex is 
[AmBn], 1 mol [AmBn] would correspond to ‘m’ mol A and ‘n’ mol B. Using this for the 
following balances, we get: 
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Regulatory Subunit balance: 
[𝑅2𝐶2]0 = [𝑅2𝐶2] + [𝑐𝑅2𝐶2] + [𝑐2𝑅2𝐶2] + [𝑐3𝑅2𝐶2] + [𝑐4𝑅2𝐶2] + [𝑐4𝑅2] + [𝑐4𝑅2𝐶] ... 49 
 (all complexes have 2 regulatory subunits (R) each) 
Catalytic subunit balance: 
2[𝑅2𝐶2]0 = 2[𝑅2𝐶2] + 2[𝑐𝑅2𝐶2] + 2[𝑐2𝑅2𝐶2] + 2[𝑐3𝑅2𝐶2] + 2[𝑐4𝑅2𝐶2] + [𝑐4𝑅2𝐶] + [𝑃𝐾𝐴
∗] ... 50 
 (all complexes have 2 catalytic subunits (C) each, except for c4R2C and PKA*) 






 ... 51 
Subtracting (49) from (51) we obtain: 
[𝑐4𝑅2𝐶] = [𝑃𝐾𝐴
∗] − 2[𝑐4𝑅2]       ... 52 
Further, the differential equations describing the dynamics of c4R2 and PKA* were written 
based on the kinetics spelt out in reaction set J in the Constants and Database of References 
section in the Supplementary material of the study by Bhalla and Iyengar. 
𝑑[𝑐4𝑅2]
𝑑𝑡
= 𝑘6𝑓[𝑐4𝑅2𝐶] − 𝑘6𝑏[𝑃𝐾𝐴
∗][𝑐4𝑅2]      ... 53 
𝑑[𝑃𝐾𝐴∗]
𝑑𝑡
= 𝑘5𝑓[𝑐4𝑅2𝐶2] − 𝑘5𝑏[𝑃𝐾𝐴
∗][𝑐4𝑅2𝐶] + 𝑘6𝑓[𝑐4𝑅2𝐶] − 𝑘6𝑏[𝑃𝐾𝐴
∗][𝑐4𝑅2]      ... 54 
Equations 48, 52, 53 and 54 thus comprise the PKA module. 




𝑚∞ = 0.5 (1 + tanh (
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𝐼𝐾 = 𝑔𝐾𝑤(𝑉 − 𝐸𝐾)         ... 4  
𝐼𝐶𝑎 = 𝑔𝑐𝑎𝑚∞(𝑉 − 𝐸𝐶𝑎)        ... 5  
𝐼𝐿 = 𝑔𝐿(𝑉 − 𝐸𝐿)         ... 6  
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Table 2.1: Symbols, defintions, values and references for the parameters used in the 






 Voltage Module   
v1 Potential at which m∞ = 0.5 -20 mV [101] 
v2 
Reciprocal of slope of voltage dependence of 
m∞ 
24 mV [101] 
v3 Potential at which w∞ = 0.5 -16 mV [101] 
v4 Reciprocal of slope of voltage dependence of w∞ 11.2 mV [101] 
gK Delayed rectifier K+ channel conductance 260 pS [101]* 
gCa VDCC conductance 600 pS [101]* 
gL Leak conductance 150 pS [101] 
gK(Ca) Calcium gated K+ channel conductance 2000 pS [101] 
EK Delayed rectifier K+ channel reversal potential -75 mV [101] 
ECa VDCC reversal potential 100 mV [101]* 
EL Reversal potential for membrane leak -75 mV [101] 
KK(Ca) Binding constant of Calcium for K(Ca) channel 5 µM [101] 
Cm Membrane capacitance 5.3 pF [101] 
ϕ 
Temperature factor that can be used to change 
the relative time constants of V and w 
35 s-1 [101] 
    
 Calcium Module   
fi 
Fraction of free intracellular Calcium 
(Note that this parameter was assumed to be 10-4 in the initial topology 









Rate constant for Calcium leak through plasma 
membrane 
150 s-1 [101] 
A 
























Rate constant for Calcium leak from ER to 
cytoplasm 
2.96×10-3 s-1 [98] 
α2 Rate constant for Calcium flux through IP3R 4.266 s-1 [98] 
α3 Binding constant of Calcium to SERCA 0.03 µM [98] 
β Volumetric average ER Calcium concentration 1.56 µM [98] 
β0 
Parameter controlling Calcium and IP3 binding 
to activating sites of IP3R 
0.349 µM [98] 
β1 Maximal activity of SERCA 0.999 µM.s-1 [98] 
β2 
Rate constant for Calcium binding to inhibitory 






Rate constant for Calcium dissociating from 
inhibitory site of IP3R with Calcium bound to 
activating and inhibiting sites 
0.018 s-1 [98] 
kPKA-cAMP 
Parameter relating [PKA*] and [cAMP] under 
quasi steady state conditions 
2 M-1 [98] 
kIP3R 














    
 cAMP Module   





Ki Inhibitory constant for Calcium binding to AC 0.2 µM 
Derived from 
[113] 
k16 Rate constant for CaM.Ca4 binding to PDE 720 (µM.s)-1 [114] 
k-16 
Rate constant for CaM.Ca4 dissociation from 
CaM.Ca4.PDE complex 
5 s-1 [114] 
CaMtot Total concentration of Calmodulin 20 µM [114] 
k1 
Equilibrium constant for Calcium binding to 
CaM 
7.5 µM [115] 
k2 
Equilibrium constant for Calcium binding to 
CaM.Ca 
2.7 µM [115] 
k3 
Equilibrium constant for Calcium binding to 
CaM.Ca2 
31 µM [115] 
k4 
Equilibrium constant for Calcium binding to 
CaM.Ca3 
31 µM [115] 




Michaelis-Menten constant for activated PDE 
complex 
40 µM [114] 
PDEt Total PDE concentration 2 µM [114] 
K3,c 
Reduced rate constant of CaM.Ca3 activated 







Reduced rate constant of CaM.Ca4 activated 







Parameter controlling Calcium independent 
PDE degradation of cAMP 
0.01 s-1 [95] 
    
 PKA Module   
K1 
























Dissociation rate of 1 catalytic subunit from 
c4R2C2 
60 s-1 [114] 
k5b Association rate of 1 catalytic subunit to c4R2C 18 (µM.s)-1 [114] 
k6f Dissociation rate of catalytic subunit from c4R2C 60 s-1 [114] 












Table 2.2: Definitions for other symbols used in the model. 
Symbol Definition 
m∞ Steady state fraction of open voltage-dependent Calcium channels 
w∞ Steady state fraction of open voltage-dependent K+ channels 
τ Time constant for the dynamics of opening probability of K+ channel 
IK Current through K+ channel 
ICa Current through VDCC 
IL Current through leak 
IK(Ca) Current through Calcium gated K+ channel 
Popen Open probability of IP3Rs 
Pmaximum Maximum probability of opening IP3R 
Ka Binding constant for activation site of IP3R 
Ki Binding constant for inhibitory site of IP3R 
ΦIP3R Calcium flux through IP3R 
jCa,V Calcium flux across plasma membrane 
jCa,I Ca flux through internal stores 
jAC cAMP synthesis flux by AC 
CaM.Can Calmodulin bound to ‘n’ Calcium ions 
CaM.Can.PDE PDE bound to CaM.Can, which is also activated PDE* complex 
ac(n) Parameter relating [CaM.Can] and [Ca2+]i 
PDE* Activated PDE complex 
jPDE cAMP degradation flux mediated by Calcium dependent PDEs 
jPDE,ind cAMP degradation flux mediated by Calcium independent PDEs 
ciR2C2 PKA homodimer (R2C2) bound to ‘i’ molecules of cAMP 
c4R2C 












Table 2.3: Initial conditions of various species and nominal values of other parameters 








V Membrane potential -20 mV I.C. 
w 
Fraction of open voltage-dependent 
K+ channels 
0.2 I.C. 
[Ca2+]i Intracellular Calcium concentration 0.5 µM I.C. 
IP3R Fraction of IP3R with Calcium bound 
to both activating and inhibiting sites 
0.4 N.V. 
cAMP Intracellular concentration of  3'-5'-
cyclic adenosine monophosphate 
0.1 µM I.C. 
R2C2 
PKA homodimer with 2 regulatory 
subunits (R) and 2 catalytic subunits 
(C) 
1 µM N.V. 
c4R2 
Complex of 4 molecules of cAMP 
bound to 2 regulatory subunits of 
PKA 
0.5 µM I.C. 
PKA* Active PKA catalytic subunits 0.2 µM I.C. 
kPKA,V 
Coefficient of modulation of calcium 
fluxes by PKA 
3×103 N.V. 
kPDE 
Coefficient of modulation of the 
maximal PDE activity 
1 N.V. 
R1 
Coefficient of modulation of binding 
constant of cAMP to PKA 
0 N.V. 
R2 
Coefficient of modulation of 






2.5.1 Gene construction 
EGFP and mCherry were PCR amplified to introduce appropriate restriction digest 
sites for subcloning into either AKAR or ICUE constructs. The genes of GR-AKAR and 
YR-ICUE were generated in pRSETB (Invitrogen) and then moved to pcDNA3 
(Invitrogen) behind a Kozak sequence for mammalian expression. ICUEPID was generated 
from CRY-AKAR (96) in pcDNA3 by replacing mVenus with the molecular switch and 
mCitrine of ICUE2.  
2.5.2 Cell Culture  
MIN6 cells were plated onto sterilized glass coverslips in 35-mm dishes and grown 
to 50–90% confluency in DMEM (10% FBS) at 37°C with 5% CO2. Cells were transfected 
using Lipofectamine 2000 (Invitrogen) and grown 20-48 h before imaging. For Calcium 
imaging experiments, cells were pre-incubated with 1 μM Fura-2/AM (Molecular Probes) 
for 10-20 min at 37 °C before imaging  
2.5.3 Imaging  
Cells were washed twice with Hanks' balanced salt solution buffer and maintained 
in the dark at room temperature. Cells were imaged on a Zeiss Axiovert 200M microscope 
with a cooled charge-coupled device camera (MicroMAX BFT512, Roper Scientific, 
Trenton, NJ) controlled by METAFLUOR 6.2 software (Universal Imaging, 
Downingtown, PA). Fura-2 dual excitation ratio imaging used two excitation filters 
[350DF10 for 350 nm excitation and 380DF10 for 380 nm excitation], a 450DRLP dichroic 
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mirror, and a 535DF45 emission filter. Dual red/green emission ratio imaging used a 
480DF30 excitation filter, a 505DRLP dichroic mirror, and two emission filters [535DF45 
for GFP and 653DF95 for RFP]. Dual red/cyan emission ratio imaging used a 420DF20 
excitation filter, a 450DRLP dichroic mirror, and two emission filters [475DF40 for CFP 
and 653DF95 for RFP]. Dual yellow/red emission ratio imaging used a 495DF10 excitation 
filter, a 600DRLP dichroic mirror, and two emission filters [535DF25 for YFP and 653DF95 
for RFP]. Dual cyan/yellow emission ratio imaging used a 420DF20 excitation filter, a 
450DRLP dichroic mirror, and two emission filters [475DF40 for CFP and 535DF25 for YFP]. 
These filters were alternated by a filter-changer Lambda 10-2 (Sutter Instruments, Novato, 
CA). Exposure time was 50–500 ms, and images were taken every 10-30 s. Fluorescence 
images were background-corrected by subtracting the fluorescence intensity of background 
with no cells from the emission intensities of cells expressing fluorescent reporters. The ratios 
of 350/380, red/green, red/cyan, yellow/red, or yellow/cyan emissions were then calculated at 
different time points. The values of all time courses were normalized by dividing each by the 
average basal value before addition of drug. 
2.5.4 Modeling  
Model was built as detailed in Section 2.4. Simulations were carried out with custom 
written MATLAB programs. The system has 6 states: membrane potential (Vm), gating 
probability of K+ channel (w), concentration of intracellular calcium ([Ca2+]i), [cAMP], 
concentration of cAMP bound regulatory subunits of PKA ([c4R2]), concentration of free 
catalytic subunit which is the active PKA ([PKA*]). Kinetic equations for calcium flux through 
the plasma membrane were based on the Chay-Keizer model and the calcium release from 
internal stores was modeled as arising out of the coordinated activities of IP3Rs and SERCAs. 
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Both the fluxes were dependent on PKA activity, thereby setting up a feedback loop. The 
increase in calcium modulates the activities of calcium-inhibitable AC6 and calcium activated 
PDE1, which in turn produce and degrade cAMP respectively. PKA is activated by the 
sequential binding of 4 molecules of cAMP and the catalytic subunit is released sequentially. 
Concentrations were normalized with respect to their respective maximal levels, for the ease 
of comparison. The programs were simulated for a sufficient time span (1000 s for traces) to 
produce sustained oscillatory patterns. Frequency of calcium oscillations was calculated using 
MATLAB’s in-built FFT routine. 
2.5.5 Western Blot Analysis  
For analysis of oscillatory changes in PKA activity, MIN6 cells were stimulated 
with 20 mM TEA and washed with ice-cold phosphate-buffered saline at different time 
points (0, 1, 2, 3, 4, 5, 6, 7, 8 min). Cells were rapidly lysed in radioimmunoprecipitation 
assay lysis buffer containing protease inhibitor cocktail, 1 mM ethylenediaminetetraacetic 
acid (EDTA), 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM NaVO4, 1 mM NaF, 
and 25 nM Calyculin A. Cell lysates were incubated on ice for 30 min and centrifuged at 
4°C for 20 min. Total protein was separated with 7.5 % SDS-polyacrylamide gel 
electrophoresis (PAGE) and transferred to nitrocellulose membranes, which were probed 
with phospho-PKA substrate or beta-tubulin antibody. Bands were visualized by enhanced 
chemiluminescence. The intensity of the bands was quantified, and the values were then 
normalized to beta-tubulin level by using UN-SCAN-IT (Silk Scientific, Orem, UT). For 
detection of nuclear PKA activity, MIN6 cells were stimulated with low dose (2 μM) or 
high dose (10 μM) of cAMP analog or 50 μM forskolin (FSK) and washed with ice-cold 
phosphate-buffered saline after 45 min incubation. Cells were then lysed as described 
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above. Total protein was separated with 7.5 % SDS-PAGE and transferred to nitrocellulose 
membranes, then probed with phospho-CREB (pS133) or CREB antibody. The intensity of the 

















Chapter 3 Decoding of calcium oscillations by the 
ERK signaling cascade 
3.1 Introduction 
The extracellular-signal regulated kinases 1/2 (ERK1/2, referred to as ERK here for 
convenience) are central components of multiple signaling pathways controlling various 
cellular functions including cell proliferation, cell survival and migration (117). In 
excitable cells, the ERK signaling cascade also interfaces with calcium to achieve non-
canonical cell type specific functions. Calcium-ERK crosstalk is deemed important for 
long term potentiation and memory formation in the brain (118), hypertrophy in the heart 
(119) and insulin production in the pancreas (120). In pancreatic beta-cells, ERK regulates 
insulin gene transcription (51) and secretory demand (121) thereby ensuring the overall 
health of the beta-cells for efficient insulin production. ERK is activated in beta-cells 
following stimulation with glucose, hormones and membrane-depolarizing agents in a 
calcium-dependent manner (52, 122, 123). However, how ERK decodes dynamically 
diverse calcium signals to regulate beta-cell functions is still unclear. 
 The canonical mode of activation of ERK which belongs to the mitogen activated 
protein kinase (MAPK) family begins with the activation of the small GTPase, Ras. Ras 
then activates the MAP Kinase Kinase Kinases, b-Raf and Raf-1 which in turn activate the 
MAP Kinase Kinase, MEK. Finally, activated MEK phosphorylates and activates ERK 
(117). Multiple candidate signaling molecules including PKA, PKC, CaMKII and PP2B 
have been suggested to activate one or more of the components of this cascade to facilitate 
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calcium-dependent ERK activation in beta-cells (52, 123-125). Here, we discovered that 
the ERK cascade in beta-cells can be activated through a calcium-dependent Ras Guanine 
Exchange Factor (RasGEF) called RasGRF2 which directly activates the canonical Ras-
MEK-ERK cascade and influences temporal dynamics of ERK activity. 
ERK activity temporal dynamics, especially oscillations (26) are thought to 
influence cell health and are mediated by complex feedback loops in other cells (90, 126, 
127). In pancreatic beta-cells, depolarization-mediated ERK activity temporal dynamics is 
dictated by calcium dynamics. Importantly, kinetic differences at different steps of the 
ERK cascade are crucial for decoding of the input calcium signal by ERK. Sequential 
processing of the signal by different components of the ERK cascade enables the cell to 
selectively achieve robust ERK activity increase while still retaining crucial dynamical 
information for use in different contexts. 
3.2 Results 
3.2.1 Calcium-ERK crosstalk  
We investigated the presence of a potential crosstalk between the calcium and ERK 
signaling pathways in MIN6 cells in two ways. First, we tested if calcium signals change 
in response to perturbation of ERK activity. To mimic the action of glucose, we treated the 
beta-cells with the potassium channel blocker, tetraethyl ammonium chloride (TEA) which 




Figure 3.1: ERK-calcium crosstalk. A. Representative time course showing calcium 
oscillations (monitored by Fura2-AM) in response to TEA in single MIN6 cells (n=55). 
B. Representative time course showing calcium response to EGF (n=26). C. 
Representative time course showing calcium response to MEK inhibitor, U0126 (20 M) 
following TEA stimulation (n=35). D. Representative time course showing calcium 
response (monitored by RCaMP) to MEK inhibitor, PD98059 (20 M) following TEA 
stimulation (n=6). E. Representative time courses of calcium (grey, monitored by 
RCaMP) and ERK activity (black, monitored by EKARcyto) in response to TEA (n=31). F. 
Representative time courses of ERK activity in response to TEA in the presence of 
calcium (grey) and in the absence of calcium (black, n=3). Norm. Em. Ratio, Normalized 
Emission Ratio; Norm. Intensity, Normalized Intensity. 
Expectedly, we observed intracellular calcium oscillations in 67 % of the cells (n = 
55) using the calcium indicator Fura2-AM (Figure 3.1A). Pre-treatment of the cells with 
the epidermal growth factor (EGF), a known agonist of the ERK signaling cascade in MIN6 
cells (128), failed to elicit any significant changes in dynamics of the calcium response 
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(Figure 3.1B) with calcium oscillations being observed in 58 % of the cells (n = 26). 
Surprisingly, however, inhibition of ERK signaling pathway achieved through the 
inhibitor, U0126 (129) disrupted the TEA-mediated oscillatory calcium signal (Figure 
3.1C) in 83 % of the oscillating cells (n=35). Similarly, inhibition of the ERK pathway 
through another inhibitor, PD98059 (130) also resulted in disruption of calcium signals 
(Figure 3.1D) in all the cells that exhibited oscillations (n=6), as monitored by the red-
fluorescent protein based calcium biosensor, RCaMP (131). This suggested a complex 
control mechanism of calcium by ERK; ERK is necessary for maintaining the TEA-
mediated calcium oscillations but ERK activation alone is not sufficient to perturb calcium 
dynamics.  
We then tested if the converse was true, i.e. if modulation of the calcium signal 
affects ERK activity.  Particularly, given the rich dynamical nature of the calcium signal 
and the ability of ERK itself to exhibit varied temporal dynamics (26, 58, 90, 132), we 
wondered if ERK decodes the calcium oscillations and/or displays dynamical signaling 
behavior in MIN6 cells. Population level techniques such as immunoblotting can mask 
dynamical changes. We therefore employed the FRET-based biosensor, ERK Activity 
Reporter (EKARcyto) to track ERK activity dynamics in real-time in the cytosol of living 
cells (20). Significantly, this technique also enabled us to monitor both the calcium and 
ERK activity signals in the same cell and therefore directly correlate the two patterns in 
each cell. We achieved this through the use of the red-shifted calcium indicator, RCaMP 
(131) so as to ensure spectral separation from the cyan and yellow fluorescence of the 
EKARcyto reporter.  
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Upon stimulation of beta-cells with TEA, ERK activity as monitored by EKARcyto 
increased concomitantly with an increase in intracellular calcium (Figure 3.1E). 
Significantly, we observed that an overwhelming majority of the cells (90 %, n= 31) 
displayed sustained ERK activity response while the calcium levels in the same cells were 
found to be oscillatory. This is in stark contrast to the behavior of another kinase, PKA 
which consistently displays activity oscillations in response to the same oscillatory calcium 
signal (see Chapter 3). Interestingly, a minor fraction of the cells (16 %, n = 31) displayed 
small ERK activity oscillations overlaid on the sustained response (Figure 3.1E) suggesting 
that ERK activity dynamics is linked to calcium dynamics. Therefore, we tested if ERK 
activity increase is mediated by calcium increase. Accordingly, we stimulated the cells with 
TEA in low extracellular calcium conditions. This condition markedly diminished the ERK 
response in all the cells (n = 3, Figure 3.1F), suggesting that TEA-dependent increase in 
ERK activity is indeed mediated by an increase in intracellular calcium levels. Therefore, 
membrane-depolarization of MIN6 cells appears to setup a calcium-ERK feedback circuit. 
Such non-linear interactions can enrich signaling diversity through complex temporal and 
spatial dynamics. We therefore set out to dissect the mechanisms of calcium-ERK signaling 
crosstalk and investigate how ERK decodes calcium oscillations in beta-cells.  
3.2.2 Mechanisms of depolarization-induced ERK activation 
ERK is typically activated by a signaling cascade involving the small GTPase, Ras 
and the kinases Raf and MEK (117). To test if ERK activation in MIN6 cells is mediated 
by this cascade, we monitored ERK activity in cells expressing EKARcyto and the dominant 
negative Ras mutant, HRasN17 (133). We observed markedly diminished ERK activity in 
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these cells (n=9) compared to control cells, in response to TEA confirming the role of Ras 
in depolarization-dependent ERK activation (Figure 3.2A). We then investigated if Ras 
itself is activated in response to intracellular calcium increase using the FRET-based 
biosensor, Raichu-EV-Ras (134) and RCaMP simultaneously. Interestingly, stimulation of 
cells with TEA resulted in calcium oscillations but an integrated Ras activity response 
(Figure 3.2B) in all the cells (n=5).  On the other hand, cells incubated in low extracellular 
calcium did not elicit calcium or Ras activity increase in response to TEA (n = 16, Figure 
3.2C) confirming that depolarization-mediated Ras activity increase is mediated by 
calcium.  
 
Figure 3.2: Role of Ras in calcium-dependent ERK activation in MIN6 cells. A. Effect of 
Ras inhibition on ERK activity B. Representative time courses of calcium (gray, 
monitored by RCaMP) and Ras activity (black, monitored by Raichu-Ras) in response to 
TEA (n=5). C. Representative time courses of Ras activity in presence (black) or absence 
(gray) of calcium (n=16). D. Calcium-sensitive RasGEFs and RasGAPs in MIN6 cells. 




One way by which calcium-mediated Ras activation and hence ERK activation 
could be achieved is through calcium-sensitive Ras Guanine Exchange Factors (cs-
RasGEFs) and Ras GTPase Activating Proteins (cs-RasGAPs) which have been previously 
demonstrated to process calcium signals to activate Ras in HeLa cells  (135, 136). We 
therefore probed for the expression of different cs-RasGEFs and cs-RasGAPs in MIN6 
cells. We discovered that the cs-RasGEFs, RasGRF1 and RasGRF2, and the cs-RasGAP, 
RASA1 are expressed in MIN6 pancreatic beta-cells (Figure 3.2D).  
RasGRF1 has been previously implicated in glucose intolerance and 
hypoinsulinemia (137). RasGRF2 which is homologous to RasGRF1 is an important player 
in the processing of calcium signals through the Ras/ERK signaling cascade in the context 
of long-term potentiation in the brain (138). We suspected that RasGRF2 may similarly be 
crucial to the ERK cascade mediated decoding of calcium signals in beta-cells. Therefore, 
we investigated the role of RasGRF2 by overexpressing a “Ras-dead” mutant of RasGRF2 
(R1092A) which prevents Ras activation (139, 140) and subsequently measured ERK 
responses in these cells. Cells expressing the mutant RasGRF2 exhibited significantly 
decreased ERK activity in response to TEA as compared to control cells expressing wild 
type RasGRF2 (Figure 3.3A) indicating that RasGRF2 is indeed necessary for calcium-




Figure 3.3: Role of RasGRF2 in ERK activation in MIN6 cells. A. ERK activity in cells 
expressing the RasGRF2-R1092A mutant (n=9) compared to cells expressing wildtype 
(WT) RasGRF2 (n=6). B. Representative time courses of RasGRF2 activation (black, 
monitored by RasGRF2-mCherry) and calcium (grey, monitored by GCaMP-Kras) in 
response to TEA (n=7). Norm. Em. Ratio, Normalized Emission Ratio. **, P<0.05. 
Having established that calcium-dependent ERK activation is mediated by 
RasGRF2, we wondered if the latter is also activated in response to calcium increase. 
Again, we turned to live-cell imaging to answer this question. Ras-GRF2 has been shown 
to translocate to the membrane upon activation (141). Hence its activation can be easily 
and elegantly tracked by tagging RasGRF2 with a fluorescent protein and monitoring 
fluorescence intensity changes in the plasma membrane. We therefore simultaneously 
monitored RasGRF2 activation (using a RasGRF2-mCherry fusion construct) and 
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concomitant calcium changes (through the plasma membrane-specific green calcium 
indicator, GCaMP-Kras (142)) in TIRF mode. Expectedly, TEA stimulation resulted in 
calcium oscillations reflected by the changes in green intensity (Figure 3.3B). Strikingly 
however, we also observed concomitant oscillatory changes in the red fluorescent intensity 
in majority of the cells (86 %, n=7), likely driven by periodic translocation of the 
RasGRF2-mCherry molecules from the cytosol to the plasma membrane. This is in stark 
contrast to the activity profiles of the downstream molecules, Ras and ERK (Figure 3.1E 
and Figure 3.2B) suggesting a sequential processing of the input calcium signal in this 
signaling cascade. We therefore set out to investigate how the ERK cascade processes the 
calcium signal. 
3.2.3 Decoding of oscillatory calcium signals by ERK pathway 
Oscillations can be simply construed as a series of pulses. Understanding what 
happens in response to a simple pulse signal can therefore enable us to better comprehend 
how the ERK cascade processes a more complex oscillatory signal. Therefore, we 
subjected the cells to a pulse signal of depolarization using potassium chloride (KCl) and 
monitored the input signal (calcium) and the output signals at different steps in the ERK 
signaling cascade (RasGRF2, Ras and ERK) (Figure 3.4A-C). Expectedly, calcium levels 
rapidly rose upon application of KCl and rapidly decreased upon washing out of the 
stimulus. The red fluorescence intensity corresponding to the mCherry tagged to RasGRF2 
also increased and decreased in tandem with calcium, detected by GCaMP-Kras (Figure 
3.4A). This indicated that the Ras-GRF2 activation is reversible and that the deactivation 
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rates of calcium and RasGRF2 are closely matched.  In contrast, the deactivation kinetics 
of Ras and ERK were considerably slower than calcium and RasGRF2 (Figure 3.4B-D).  
 
Figure 3.4: Kinetics of different components of the ERK signaling cascade. A. 
Representative time course of RasGRF2 (black, monitored by RasGRF2-mCherry) and 
calcium (grey, monitored by GCaMP-Kras) to pulse of KCl stimulation (n=19). B. 
Representative time course of Ras (black, monitored by Raichu-Ras) and calcium (grey, 
monitored by RCaMP) to pulse of KCl stimulation (n=8). C. Representative time course 
of ERK activity (black, monitored by EKARcyto) and calcium (grey, monitored by RCaMP) 
to pulse of KCl stimulation (n=8). D. Deactivation kinetics (t1/2 (min)) of calcium, 
RasGRF2, Ras and ERK. **, P<0.05. ***, P<0.005. 
Further, we confirmed that this is not an artifact of the biosensor. The deactivation 
kinetics of ERK can in fact be accelerated when the upstream kinase of ERK, MEK is 
inhibited in combination with the KCl washout (Figure 3.5). We hypothesized that the slow 
deactivation kinetics of ERK is responsible for the integration of the oscillatory calcium 
signal. Furthermore, the gradual change in the deactivation kinetics at different steps of the 
cascade suggests a sequential and gradual processing of the calcium signal. We set out to 
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test the hypothesis that the mismatch in deactivation kinetics of input and output signaling 
modules causes the integration of oscillatory input signals.  
 
Figure 3.5: Accelerated deactivation of EKAR through combined washout and MEK 
inhibition. Deactivation kinetics of ERK activity in response to washout of KCl (n=8) 
compared to combination of washout and MEK inhibition through U0126 (n=19). **, 
P<0.05 
First, we quantified the apparent activation and deactivation kinetic parameters of 
the signaling cascade by measuring the maximal steady state ERK response at different 
doses of external calcium (Figure 3.6A). We then built a representative mathematical 
model of this signaling cascade incorporating the estimated parameters (See methods for 
details). The model was then validated by simulating the system with a series of calcium 
pulses with temporal features similar to those experimentally observed in response to TEA 
stimulation. As expected, integrated ERK activity increase was observed in accordance 




Figure 3.6: Calcium-ERK model development. A. Dose response of ERK activity increase 
(measured by EKARcyto) in response to calcium increase (measured by RCaMP). B. 
Simulation of model in response to oscillatory membrane depolarization. 
A clear advantage of a computational model is the ability to rapidly and 
inexpensively test hypotheses. Processing of the signals due to mismatches in deactivation 
kinetics implies a clear frequency-dependent effect. Under high frequency conditions, the 
output signal would be expected to integrate the input oscillatory signal. However when 
presented with a low frequency stimulus, i.e. given sufficient time between successive 
pulses of stimuli, the output ERK activity decrease following the first pulse may be able to 
reach its basal level before responding to the next pulse resulting in oscillatory instead of 
integrated ERK activity patterns. We used the model to test this hypothesis by running 
simulations of ERK activation at different frequencies of input stimuli. ERK activity was 
found to integrate (Figure 3.7A) at high frequency (1.67 milliHz) of input signal but 
oscillatory (Figure 3.7B) when the input signal frequency was low. Experimental validation 
confirmed that the ERK system discerns frequency-dependent information (Figure 3.7C-




Figure 3.7: Frequency-dependence of temporal ERK activity dynamics. A. Model 
simulation of ERK activity (black) in response to high frequency calcium oscillations 
(red). B. Model simulation of ERK activity (black) in response to low frequency calcium 
oscillations (red). C. Representative time course of ERK activity (black, monitored by 
EKARcyto) of high frequency calcium oscillations (red, monitored by RCaMP) evoked by 
pulses of KCl stimulation (shaded in grey) (n=7). D. Representative time course of ERK 
activity (black, monitored by EKARcyto) of low frequency calcium oscillations (red, 
monitored by RCaMP) evoked by pulses of KCl stimulation (shaded in grey) (n=9). 
Norm. Em. Ratio, Normalized Emission Ratio; Norm. Intensity, Normalized Intensity. 
Increasing the frequency of calcium oscillations to a value higher than the 
physiological frequency through inhibition of phosphodiesterases (77) did not change the 
ERK activity levels suggesting that ERK is maximally activated at the physiological 
frequency (Figure 3.8). Therefore, the ERK signaling cascade in MIN6 cells appears to act 
as a ‘low-pass filter’ for processing the input signal, similar to homologous pathways in 
worms (143) and NIH 3T3 cells (144). Furthermore, the filtering of high frequency signals 
enables ERK to be robustly activated at the physiological frequency. We then investigated 
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how upstream components of the cascade process the oscillatory calcium signals given 
their widely different deactivation kinetic parameters.  
 
Figure 3.8: Effect of high frequency calcium oscillations on ERK activity dynamics. 
Representative time course of ERK activity (black, monitored by EKARcyto) and calcium 
(grey, monitored by RCaMP) in response to PDE inhibition through IBMX (n=6). 
As in the case of ERK, we observed oscillatory Ras activity at low input frequencies 
but integrated Ras activity at high frequencies (Figure 3.9A-B). In contrast, RasGRF2 
which has faster deactivation kinetics compared to Ras and ERK (Figure 3.4D) was found 
to be oscillatory in the range of frequencies that we tested (Figure 3.9C-D), confirming that 
the deactivation kinetics is critical in the processing of the oscillatory calcium signals in 
the ERK cascade. Significantly, the gradual increase in kinetics and the resultant gradual 
processing of the calcium signals at each step in the cascade suggested to us that the 
capacity to filter out high frequency signals will also differ at different levels of the cascade. 
To quantitatively test this hypothesis, we measured the “Gain,” defined as the ratio of 
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amplitudes of output to input signals at each step of the cascade. Accordingly, when the 
output module faithfully reproduces an input oscillatory signal, the system has a high gain. 
In contrast, a low gain scenario indicates processing of an oscillatory signal to a sustained 
output.  
 
Figure 3.9: Frequency-dependence of Ras and RasGRF2 temporal dynamics. A. 
Representative time course of Ras activity (black, monitored by Raichu-Ras) of high 
frequency calcium oscillations (red, monitored by RCaMP) evoked by pulses of KCl 
stimulation (shaded in grey) (n=5). B. Representative time course of ERK activity (black, 
monitored by Raichu-Ras) of low frequency calcium oscillations (red, monitored by 
RCaMP) evoked by pulses of KCl stimulation (shaded in grey) (n=6). C. Representative 
time course of RasGRF2 activation (black, monitored by RasGRF2-mCherry) of high 
frequency calcium oscillations (red, monitored by GCaMP-Kras) evoked by pulses of KCl 
stimulation (shaded in grey) (n=6). D. Representative time course of Ras activation 
(black, monitored by RasGRF2-mCherry) of low frequency calcium oscillations (red, 
monitored by RCaMP) evoked by pulses of KCl stimulation (shaded in grey) (n=6). 




Figure 3.10: Sequential filtering of calcium signals. A. Change in gain as a function of 
frequency at different steps of the cascade, RasGRF2 (orange), Ras (green) and ERK 
(cyan) and the sequential filtering of high frequency signals represented by grey shaded 
areas, determined by an arbitrary threshold (grey, dashed). B. Representative time 
course of Rac1 activity response (black, monitored by Raichu-Rac1) and calcium 
oscillations (grey, monitored by RCaMP) in response to TEA (n=10). Norm. Em. Ratio, 
Normalized Emission Ratio; Norm. Intensity, Normalized Intensity. 
In response to different frequencies of stimulation, ranging from 0.55 milliHz to 
1.67 milliHz, RasGRF2 was found to have a consistently high gain thanks to its ability to 
faithfully reproduce the calcium oscillations (Figure 3.10A). On the other hand, the effector 
of RasGRF2, Ras which has slower deactivation kinetics compared to RasGRF2 exhibits 
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high gain at low frequencies but gradually filters out high frequency signals resulting in 
low gain at high frequencies. Strikingly, ERK, which has slower deactivation kinetics has 
a much stronger filtering capacity. As a result of this filtering process, ERK is activated in 
a robust manner. However, at the same time, the gradual filtering of high frequency signals 
through the cascade could still endow the signaling pathway with the ability to use the 
dynamical information, especially at the level of upstream signaling components of the 
cascade through activation of other signaling molecules. For instance, RasGRF2 is an 
activator of not only Ras but also another small GTPase, Rac1 which regulates insulin 
secretion through actin remodeling (145). We therefore set out to monitor the signaling 
dynamics of Rac1 activity changes in response to membrane depolarization, using the 
FRET-based biosensor, Raichu-Rac1. In response to TEA stimulation, we observed that 
Rac1 activity oscillates in tandem with calcium (Figure 3.10B) in a majority of the cells 
(60%, n=10) indicating that the dynamical information at the level of RasGRF2 is still 
retained in the Rac1 branch while the same signal is processed to produce a robust and 
sustained ERK response. 
3.3 Discussion 
In this study, we investigated how ERK interfaces with calcium in pancreatic beta-
cells. Calcium and ERK regulate each other in a complex fashion. ERK is necessary but 
not sufficient for maintaining the oscillatory nature of calcium in response to glucose-
mimicking agents like TEA. The mechanisms by which ERK may modulate calcium are 
not clear. Previously, we showed that PKA is also necessary for maintaining calcium 
oscillations (77). PKA is activated by cAMP which in turn is degraded by 
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phosphodiesterases. One such phosphodiesterase, PDE4 is known to be inhibited by ERK 
(146). Therefore, ERK may positively regulate PKA activity. It is conceivable that 
inhibition of ERK attenuates PKA activity and thus modulates calcium. Future experiments 
aimed at identifying PDE4-ERK interactions, if any, in beta-cells will help address this 
question. Calcium, on the other hand, is necessary and sufficient to activate ERK in 
response to membrane-depolarizing agents. Calcium-dependent ERK activity increase is 
necessarily mediated by Ras. Ras, in turn, is likely activated through the actions of the 
calcium-sensitive RasGRF2 whose role in mediating calcium-dependent ERK activation 
has been previously documented in neurons (138) and fibroblasts (147). Here, we 
demonstrated for the first time that RasGRF2 mediates calcium-dependent ERK activation 
in pancreatic beta-cells.  
The intricate calcium-ERK crosstalk in MIN6 beta-cells also provides insight into 
general signaling mechanisms on multiple fronts. First, the presence of a calcium-ERK 
feedback ensures proper calcium signaling in beta-cells. Persistent oscillations require a 
combination of positive and negative feedback loops (30). In this study, we demonstrate 
that the ERK-calcium positive feedback loop is necessary for sustaining these oscillations 
with the result that inhibition of ERK leads to disruption of the oscillations. The calcium-
ERK feedback loop is therefore a crucial component of the signaling mechanisms that 
govern beta-cell function like insulin secretion through robust calcium oscillations.  
Second, the calcium-dependent changes in the dynamics of ERK activity highlight 
how ERK decodes calcium signals in beta-cells. TEA-induced calcium oscillations result 
in sustained and thus high time-averaged ERK activity. However, lower frequency calcium 
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oscillations elicit oscillatory ERK activity changes with lower time-averaged ERK activity 
as in the case of HeLa cells (148) and worm neurons (143) suggesting that frequency-
dependent decoding of calcium by ERK may be a widespread phenomenon. 
Characterization of the frequency response of the ERK homolog protein, Hog-1 in yeast 
(149, 150) indicated that Hog-1 acts as a band-pass filter owing to a negative feedback loop 
in the Hog-1 signaling cascade. In the MIN6 system, however, we observe a low-pass filter-
like response for ERK in the frequency range that we tested with the result that the cascade 
filters out high frequency signals to produce a robust and sustained ERK activity increase 
in response to TEA.  
Finally, the decoding of calcium signals by the ERK signaling cascade sheds light 
on how cells may leverage temporal dynamics to transmit information. The differences in 
temporal dynamics of calcium and various signaling molecules in the ERK signaling 
cascade result in gradual and sequential processing of the signal down the cascade. While 
ERK and Ras filter out high frequency signals, upstream components like RasGRF2 retain 
the capacity to be oscillatory in the entire frequency range that we tested. As a result, 
RasGRF2 can make use of this dynamical information at the same time in other contexts. 
Specifically, in contrast to Ras, Rac1, another target of RasGRF2 oscillates in response to 
TEA likely affecting actin dynamics and hence insulin secretion (151, 152). 
3.4 Methods 
3.4.1 Construction of RasGRF2-mCherry 
Murine RasGRF2 clone was obtained from the Ultimate™ ORF Collection. 
RasGRF2 was PCR amplified, digested and cloned into a pRSETB plasmid between 
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BamHI and SacI restriction sites. The red fluorescent protein mCherry was inserted 
between SacI and EcoRI sites. The RasGRF2-mCherry fusion was then subcloned into 
pCDNA3 (Invitrogen) between BamHI and EcoRI sites.  
3.4.2 Cell Culture  
MIN6 cells were seeded onto sterilized glass coverslips in 35-mm dishes and grown 
to 50–90% confluency in DMEM (10% FBS) at 37°C with 5% CO2. Cells were transfected 
using Lipofectamine 2000 (Invitrogen) and grown for 48 h after transfection before the 
imaging.  
3.4.3 Imaging  
Cells were washed twice with HBSS (Hanks' balanced salt solution) buffer and 
maintained in the dark at room temperature.  
3.4.4 Epifluorescence Microscopy  
Cells were imaged on a Zeiss Axiovert 200M microscope with a cooled charge-coupled 
device camera (MicroMAX BFT512, Roper Scientific, Trenton, NJ) controlled by 
METAFLUOR 6.2 software (Universal Imaging, Downingtown, PA). Yellow/cyan emission 
ratio imaging used a 420DF20 excitation filter, a 450DRLP dichroic mirror and two emission 
filters (475DF40 for CFP and 535DF25 for YFP) alternated by a filter-changer Lambda 10-2 
(Sutter Instruments, Novato, CA). RCaMP emission was monitored using 568DF55 excitation 
filter, 600DRLP dichroic mirror, and 653DF95 emission filter. Exposure time was 50–500 ms, 
and images were taken every 15-30s. Fluorescence images were background-corrected by 
subtracting the fluorescence intensity of background with no cells from the emission intensities 
of cells expressing fluorescent reporters. The ratios of yellow/cyan emissions were then 
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calculated at different time points. Both Yellow/Cyan ratio and RFP intensity of all time 
courses were normalized by dividing each value by the average basal value before 
stimulant/inhibitor addition. 
3.4.5 TIRF microscopy  
Cells were imaged on a Nikon Ti-Eclipse inverted microscope equipped with a 70-mW 
air-cooled argon ion laser and a 100-mW Coherent Sapphire 561-nm laser under a 100X oil-
immersion objective from the same manufacturer. Total-internal-reflection excitation was 
achieved using manufacturer-installed TIRF setup on home-made glass-bottom dishes. 
Excitation was selected using preset dual band dichroic mirrors, while the fluorescent 
emissions were filtered using the following preset filter: GFP/RFP (Chroma number 89002). 
The filtered fluorescence was imaged using a PhotoMetrics Evolve 512 × 512 electron-
multiplied CCD camera at 16-bit.  
3.4.6 Calcium-ERK model 
Steady state ERK activity was measured in response to different doses of external 
calcium (0.05 mM, 0.1 mM, 0.25 mM, 0.5 mM, 1.2 mM, 2 mM). The normalized EKAR 
response was quantified as a function of normalized RCaMP response and fit to a function 





where ‘yss’ represents normalized steady state EKAR response and ‘xss’ represents 
normalized steady state RCaMP response. In order to predict the dynamical EKAR 
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response to changes in calcium, represented by RCaMP, we assumed a simple 1st order 







The parameters Vm and Km were estimated as detailed above. Given that the analytical 
solution to this equation is of the form: 
𝑦 = 𝑦𝑠𝑠(1 − 𝑒
−𝑘𝑟𝑡) 






where 1/2 is the experimentally measured half-maximal deactivation kinetics. 
Differential equations representing RCaMP and EKAR changes were written in custom 
MATLAB scripts and solved using the ode4 solver. Pulses of width 5 minutes and time 









Chapter 4 Spatial dynamics of ERK signaling in 
pheochromocytoma PC12 cells 
4.1 Introduction 
The prototypical ERK signaling cascade exemplifies the intricate regulatory 
mechanisms employed by cells to effect different functional responses using 
spatiotemporal dynamics.  One of the first clues pointing to the role of ERK signaling 
dynamics in cellular decision making were uncovered when researchers observed that 
sustained ERK signaling in response to nerve growth factor (NGF) stimulus results in 
differentiation of PC12 cells. On the other hand, an EGF stimulus evokes a transient ERK 
activity response resulting in proliferation (58). These cell fates are determined by the 
differential expression of certain genes, which in turn are dependent on ERK signal 
duration. In fact, it has been shown that sustained ERK activity following NGF stimulus 
can phosphorylate and stabilize the transcription factor, Fos. On the other hand, an EGF-
mediated transient increase in ERK activity is insufficient to stabilize any Fos proteins that 
may be produced (153). Differential regulation of the transcription factor activity can then 
influence cellular fate. Although the role of temporal ERK dynamics in influencing cellular 
processes have been well studied, very little is known about the spatial differences in ERK 
activity and how that affects cell functions. 
One of the key challenges in the study of spatial signaling dynamics has been the 
lack of convenient tools that can probe biochemical activities at various locations inside 
the cell. Subcellular fractionation, the standard technique for doing this is a long and 
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complicated procedure also requiring the lysis of cells thereby losing crucial live-cell 
information in the process. Here, we harnessed the power of genetically encoded FRET-
based biosensors by targeting them to different locations within the cells and obtained real-
time, spatiotemporal changes in ERK activity in live cells. As a result, we were able to 
uncover interesting spatial differences in ERK activity patterns in PC12 cells.  
Investigations into the mechanisms of these differences led us to discover a complex 
location-dependent crosstalk between the cAMP-PKA and ERK pathways. The cells 
appear to use such spatial differences in signaling network topology to dictate biochemical 
activity and thus modulate cell functions, especially those that may be associated to specific 
subcellular locations. In PC12 cells, the distinct spatiotemporal dynamics of plasma 
membrane ERK activity are crucial for influencing plasma membrane-specific functions 
like cellular adhesion.  
4.2  Results 
4.2.1 Spatial differences in ERK activity dynamics 
To monitor spatial dynamics of ERK activity in PC12 cells, we used the FRET-
based reporter, EKAR whose power to provide temporal information was demonstrated in 
Chapter 3. The genetic encodability of this reporter is a major advantage endowing the user 
with the power to target this reporter to specific locations within the cell and obtain crucial 
spatial information. Targeted reporters however can suffer from losses in dynamic range 
and thus significant decrease in signal to noise ratio thereby affecting the ability to 
confidently measure activity changes. We therefore generated and used an improved 
version of EKAR (dubbed EKAR2.3 here) based on the optimized sensor, EKAR-EV 
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developed by Matsuda and colleagues (154). We then fused different targeting sequences 
to this sensor to direct it to specific organelles, generating an arsenal of organelle-specific 
ERK activity reporters: EKAR2.3-PM (non-lipid raft plasma membrane), LR-EKAR2.3 
(lipid rafts), EKAR2.3-Cyto (cytosol), EKAR2.3-Nuc (nucleus), Mito-EKAR2.3 (outer 
mitochondrial membrane) and Golgi-EKAR2.3 (golgi apparatus). 
These reporters were expressed in PC12 cells. The reporters were found to localize 
to their expected subcellular compartments ensuring that the information obtained from the 
targeted EKARs is in fact location-specific (Figure 4.1). We then monitored the FRET 
changes from the reporters in real time in response to growth factor stimulation. Upon 
stimulation with the Nerve Growth Factor (NGF) which drives the differentiation of PC12 
cells into neurite-like cells (155), we observed robust and sustained ERK activity response 
in all the sub-cellular compartments (Figure 4.2). In contrast, when the cells were exposed 
to the Epidermal Growth Factor (EGF) which causes the PC12 cells to proliferate (156), 
we observed striking differences in ERK activity at different locations (Figure 4.3). The 
cytosolic and nuclear responses mirrored that of the documented whole cell transient ERK 
activity response (157-159). In stark contrast, the ERK activity in non-lipid raft plasma 
membrane, lipid rafts and golgi apparatus was sustained while the mitochondrial ERK 




Figure 4.1: Localization patterns of targeted EKARs 
 
Figure 4.2: Time courses of ERK activity at different locations in response to NGF 
(individual responses in grey, mean in black). A. Cytosol (n=15). B. Plasma membrane 
(PM, n=10). C. Lipid rafts (LR, n=9). D. Nucleus (n=12). E. Mitochondria (n=9). F. 




Figure 4.3: Time courses of ERK activity at different locations in response to EGF 
(individual responses in grey, mean in black). A. Cytosol (n=33). B. Plasma membrane 
(PM, n=26). C. Lipid rafts (LR, n=28) D. Nucleus (n=13). E. Mitochondria (n=18). F. 
Golgi apparatus (n=18). 
In order to quantify these differences, we employed the Sustained Activity Metric 





where R0 and R40 are the response amplitudes at 0 and 40 minutes respectively, and Rp is 
the maximum response measured between 0 and 40 minutes. The choice of 40 minutes as 
the window limit was based on the observation that ERK activity reaches steady state by 
that time. A SAM value of 1 thus indicates that the response is perfectly sustained while a 
SAM value of 0 corresponds to a perfectly adapted transient response. In general, 
comparing two responses, the one with higher SAM value is more sustained than the other. 
The SAM values for the different subcellular compartments in response to EGF and NGF 
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are shown in Figure 4.4 and Figure 4.5. Corroborating our earlier qualitative observations, 
the cytosolic SAM is nearly half of the plasma membrane SAM in response to EGF 
implying that the plasma membrane responses are much more sustained than that of the 
cytosol. On the other hand, in response to NGF, the SAMs were found to be consistently 
high in all compartments save the mitochondria with no significant difference between the 
plasma membrane and cytosolic ERK activity.  
 
Figure 4.4: Comparison of Sustained Activity Metric at different locations in response to 
EGF stimulation. PM, plasma membrane; LR, lipid rafts; Mito., mitochondria; Golgi, 





Figure 4.5: Comparison of Sustained Activity Metric at different locations in response to 
NGF stimulation. PM, plasma membrane; LR, lipid rafts; Mito., mitochondria; Golgi, 
Golgi apparatus; Cyto., cytosol; Nuc., nucleus. ***, P<0.005. n.s. not significant 
4.2.2 Mechanisms 
Having established clear and significant spatial differences in ERK activity in 
response to EGF, we investigated the mechanisms by which such differences may be 
established upon exposure to EGF. Specifically, we focused on the two ‘extremes’ that 
exemplify this pattern, namely the cytosol and the non-lipid raft plasma membrane 
(referred to as plasma membrane hereafter). The activity of ERK as measured by EKAR is 
indicative of the phosphorylation status of a typical ERK substrate. Phosphorylation of a 
signaling molecule is a dynamical process that is finely regulated not just by the kinase but 
also by the countering actions of phosphatases. It is therefore conceivable that the 
differences in ERK activation patterns in the plasma membrane and cytosol are the result 
of differences in the accessibility to phosphatases for an ERK substrate at these two 
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locations. In order to test this, we measured the ERK activity changes in cytosol and plasma 
membrane upon inhibition of the ERK signaling cascade following EGF stimulation. This 
exercise was motivated by the reasoning that the rate of change in ERK activity may be 
simply described as follows: 
𝑑[𝑆𝑢𝑏𝑎𝑐𝑡𝑖𝑣𝑒]
𝑑𝑡
= 𝑘𝑓[𝐼𝑛𝑝𝑢𝑡] − 𝑘𝑟[𝑃ℎ𝑜𝑠𝑝ℎ𝑎𝑡𝑎𝑠𝑒𝑠] 
where [Subactive] denotes the concentration of active substrate (and hence ERK activity) 
that is controlled by both the input kinase signaling pathway and phosphatases. Upon 
inhibition of the pathway, the rate of change in ERK activity reduces to just a simple 
function of the phosphatases. Hence, we monitored the slope (rate of change in ERK 
activity) in response to inhibition of the ERK pathway through U0126 after stimulation 
with EGF. The cytosolic slope was found to be significantly steeper than that of the plasma 




Figure 4.6: Subcellular differences in rate of change of ERK activity in response to MEK 
inhibition through U0126. A. Representative time course of plasma membrane ERK 





Figure 4.7: EKAR slope measurements determine phosphatase contribution. Rate of 
change of EGF-mediated ERK activity following U0126 addition. PM, plasma membrane 
(n=17); Cyto., cytosol (n=20). ***, P<0.005. 
Spatiotemporal kinase activity dynamics is dependent not only on phosphatases but 
also the kinase itself. If ERK is regulated by other signaling molecules differently in 
different compartments, it could serve to explain these spatial differences. Previously, 
Herbst et al. showed that ERK is modulated by the cAMP-PKA signaling pathway (25). 
The cAMP-PKA pathway exhibits spatial dynamics affecting cellular function (8, 22, 160). 
We therefore wondered if ERK is regulated distinctly by the cAMP-PKA pathway in a 
location-specific manner resulting in the spatial differences of ERK activity. 
We set out to investigate this hypothesis by measuring cytosolic and plasma 
membrane ERK activity in response to PKA inhibition. Accordingly, the cells were pre-
treated with the PKA inhibitor, H89 (20 M) for 20 minutes before stimulating with EGF. 
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We observed that the plasma membrane ERK response was drastically reduced indicating 
that PKA is necessary for regulating ERK in the plasma membrane (Figure 4.7A). The 
cytosolic ERK response was found to be strikingly different. PKA inhibition resulted in 
potentiation of ERK activity (Figure 4.8B) albeit with a slight delay in the induction of the 
activity indicating that the cytosolic pool of ERK is regulated by PKA in a complex fashion. 
We then confirmed these results by treating the cells with a peptide based inhibitor of PKA, 
myristoylated PKA (MyrPKI) prior to EGF stimulation. In order to quantify these results, 
the integrated ERK activity over 40 minutes was measured in response to PKA inhibition 
and control treatments (Figure 4.9). The resulting patterns indicate that the EGF-dependent 
spatiotemporal ERK activity dynamics appear to be modulated by compartment-specific 
regulation of ERK by PKA. The plasma membrane ERK activity is reduced upon treatment 
with MyrPKI while the cytosolic ERK activity is unaffected. The lack of significant 
potentiation of cytosolic ERK activity in response to MyrPKI is likely because MyrPKI  




Figure 4.8: Subcellular differences in ERK activity following PKA inhibition. A. 
Representative time course of plasma membrane ERK activity in absence of (grey) and in 
response to (black) PKA inhibition (n=15). B. Representative time course of cytosolic 




Figure 4.9: Spatial differences in integrated ERK activity following PKA inhibition. A. 
Integrated plasma membrane ERK activity in response to PKA inhibition through H89 
(n=15) or myristoylated PKI (MyrPKI, n=23). B. Integrated cytosolic ERK activity in 
response to PKA inhibition through H89 (n=14) or myristoylated PKI (MyrPKI, n=22). 




We then set out to investigate if the EGF-dependent spatial differences in ERK 
activity can be modulated through elevation of PKA activity.  Therefore, we exposed the 
cells to the generic phosphodiesterase inhibitor, IBMX which is expected to elevate the 
intracellular cAMP concentration and hence cause elevation of PKA activity. Contrary to 
expectations, we noticed decreased ERK activity in the plasma membrane and sustained 
activity in the cytosol in response to EGF stimulation following IBMX treatment (Figure 
4.10).  
Quantifying these results by integrating the ERK activity over the experimental 
time window of 40 minutes, we uncovered an interesting biphasic pattern of regulation of 
ERK by the cAMP-PKA pathway (Figure 4.11). In response to both PKA activity elevating 
and inhibiting agents, we observed decreased integrated ERK activity in the plasma 
membrane. In contrast, the integrated cytosolic ERK activity exhibited a reciprocal 
relationship with the plasma membrane activity. In response to both H89 and IBMX, the 
cytosolic ERK activity was increased compared to the control treatment with EGF alone. 
Therefore, in summary, the spatiotemporal differences in ERK activity are mediated by 
differential access to phosphatases at different locations and a complex control mechanism 
of the ERK signaling cascade through the cAMP-PKA signaling pathway. Having 
established these underlying mechanisms of spatiotemporal ERK dynamics, we 
investigated the functional roles of such spatiotemporal regulation. Specifically, we 
wondered if the potentiated ERK activity in the plasma membrane may be necessary for 




Figure 4.10: Subcellular differences in ERK activity mediated by activation of cAMP-
PKA pathway. A. Representative time course of plasma membrane ERK activity in 
absence of (grey) and in response to (black) PDE inhibition through IBMX (n=12). B. 
Representative time course of cytosolic ERK activity in absence of (grey) and in response 





Figure 4.11: Spatial differences in ERK activity response to modulation of cAMP-PKA 
pathway. A. Integrated plasma membrane ERK activity in response to PKA inhibition 
(through H89, n=15) and cAMP-PKA elevation (through IBMX, n=12). B. Integrated 
cytosolic ERK activity in response to PKA inhibition (through H89, n=15) and cAMP-
PKA elevation (through IBMX, n=16). ***, P<0.005. **, P<0.05. 
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4.2.3 Functional implications 
The plasma membrane of a cell is the interface between cellular constituents and 
the environment and therefore dictates processes that require interactions with the 
surroundings such as cellular adhesion. Optimal adhesion of cells to surfaces is vital to 
overall cell function with implications ranging from maintaining integrity of epithelial 
tissues (161) to the diseased state of tumor metastasis (162). PC12 cells have been 
demonstrated to exhibit increased cellular adhesion when exposed to EGF compared to 
control cells (163) although the molecular events regulating such a process are unclear. In 
cancer cells, ERK has been implicated in the regulation of cellular adhesion to the 
extracellular matrix through the actions of its effector molecule, the Ribosomal S6 Kinase 
(RSK) (164, 165). We therefore wondered if the spatiotemporal dynamics of ERK activity 
following EGF treatment affects PC12 cell adhesion.  
We observed that cells exposed to the ERK pathway inhibitor, U0126 increased the 
capacity of the PC12 cells to adhere to plastic (Figure 4.12, see Methods for details of the 
assay) suggesting that ERK may negatively regulate cell adhesion. Additionally, we 
confirmed this using ERK monobody binders (EMBers) that are known to inhibit ERK 
activity (166). We used two different binders dubbed EMBer7.1 and EMBer7.9 that are 
specifically targeted to the plasma membrane. As can be seen in Figure 4.13, the EMBer-
mediated knock down of ERK activity resulted in greatly increased adhesion of cells to the 




Figure 4.12: Cell adhesion changes mediated by MEK inhibitor, U0126. Norm. 
fluorescence, Normalized fluorescence. *, P<0.1. 
 
Figure 4.13: Cell adhesion changes mediated by ERK binders. Norm. fluorescence, 
Normalized fluorescence. WT, wildtype cells. 7.1, EMBer-7.1. 7.9, EMBer-7.9. ***, 
P<0.005. 
We then investigated if the plasma membrane pool of ERK may be directly related 
to the modulation of cell adhesion. In order to test this, we made use of the spatial 
differences in ERK activity patterns that result following modulation of the cAMP-PKA 
pathway (Figure 4.11). The ERK pathway inhibitor, U0126 is expected to achieve global 
inhibition of ERK; hence increased cell adhesion could be theoretically attributed to either 
the plasma membrane pool or the cytosolic pool or both. However, by exposing the cells 
to H89 or IBMX, which specifically decrease the plasma membrane ERK activity while 
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retaining high cytosolic ERK activity we argued that any increases in cell adhesion may be 
specifically connected to the plasma membrane ERK pool. Strikingly, we observed 
significantly increased cellular adhesion in response to H89 and IBMX treatments (Figure 
4.14) suggesting that the plasma membrane pool of ERK may be involved in modulating 
cell adhesion. In other words, the sustained plasma membrane ERK activity which results 
in higher integrated activity may be necessary to achieve optimal cell adhesion. 
 
Figure 4.14: Modulation of cell adhesion through cAMP-PKA pathway. Norm. 
fluorescence, Normalized fluorescence. **, P<0.05. 
4.3 Discussion 
While temporal aspects of ERK signaling have been studied in detail, very little is 
known about the spatial dynamics of ERK signaling. It’s well known that EGF and NGF 
cause widely different temporal ERK activity dynamics in PC12 cells. Here, we showed 
that these two stimuli result in completely different spatial patterns of signaling as well. 
NGF stimulation results in consistently sustained ERK activity in various sub-cellular 
organelles; however, EGF stimulation results in a range of ERK activity profiles – from 
transient profiles in the cytosol and nuclear to sustained profiles in plasma membrane and 
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other organelles – suggesting that these growth factors may have widely differing signaling 
mechanisms in different subcellular locations. These differences in subcellular 
phosphorylation patterns of ERK substrates may be caused by a variety of factors. 
Phosphorylation is the result of a dynamic balance between the kinase and cognate 
phosphatase actions. Spatial gradients in phosphorylation have been predicted to occur 
through differences in the relative concentrations of kinase and phosphatase at different 
locations (167). In this study, we discovered that plasma membrane ERK cascade has low 
access to phosphatases leading to sustained phosphorylation levels while the cytosolic 
counterpart has higher access to phosphatases resulting in transient phosphorylation.  
Coincidentally, similar subcellular phosphatase differences in the ERK cascade have been 
noted in baby hamster kidney (BHK) cells as well (168). MEK, ERK and its substrates are 
regulated by a large number of phosphatases including PP2A and multiple dual-specificity 
phosphatases (169). Future investigations into the subcellular localization patterns of these 
phosphatases and their differential spatial signaling patterns, if any, will help us better 
understand the spatial ERK signaling mechanisms. 
Aside from the phosphatase, the kinase ERK is also differentially regulated. The 
spatiotemporal ERK activity dynamics differences appear to be the result of dissimilar 
regulation of ERK cascade by the cAMP-PKA pathway. The cAMP-PKA pathway 
stimulates ERK in some cells and inhibits it in others through various targets including 
different Raf isoforms (170). In fact, B-Raf is deemed necessary for sustained ERK 
activation upon NGF stimulation in PC12 cells (171). It is likely therefore, subcellular 
differences in relative concentrations of the Raf isoforms within the same cell could 
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produce such distinct temporal ERK activity patterns. Alternatively, the effects of cAMP 
could be mediated through PKA-dependent and PKA-independent mechanisms 
simultaneously. Epac, another effector of cAMP has been previously demonstrated to 
switch PC12 cells from a proliferative state to differentiable state (172). The balance 
between PKA-dependent and Epac-dependent activation of ERK in different 
compartments could therefore likely determine ERK activity dynamics.  
EGF-dependent ERK signaling in PC12 cells has largely been understood to be 
necessary for cell proliferation. However, spatial differences in EGF-dependent ERK 
signaling may be important for location-specific functions. For instance, ERK is involved 
in mitochondrial energetics (173) and apoptosis (174, 175) likely affecting brain function 
(176) and plays an important role in golgi fragmentation (177). It is therefore likely that 
differential kinetics of ERK activity at these locations compared to cytosolic and nuclear 
ERK responses are important for regulating local substrates involved in apoptosis and golgi 
fragmentation. However, very little is known about the role of ERK in the plasma 
membrane. Here, we showed that ERK signaling is critical for modulating cell adhesion. 
Specifically, the plasma membrane pool of ERK appears to be involved in regulating this 
process. As a result, cells can exploit spatial dynamics of the same signaling molecule to 
regulate different cellular processes simultaneously. The transient ERK activity output in 
the nucleus mediates cell proliferation processes; at the same time a sustained output in the 




4.4.1 Generation of subcellular targeted EKARs 
The EKAR-EV construct was kindly donated by the Matsuda Lab. The “core” of 
EKAR-EV comprising the phospho-amino acid binding WW domain, EV linker and 
substrate domain was PCR amplified, digested and subcloned into pRSETB plasmid 
between SphI and SacI restriction sites. The fluorescent proteins ECFP and YPet were 
inserted between BamHI and SphI, and SacI and EcoRI sites respectively. This construct 
was then subcloned into a pC3DNA (Invitrogen) plasmid between the BamHI and EcoRI 
sites and was dubbed EKAR2.3. In order to generate the targeted versions of EKARs, 
appropriate targeting sequences were inserted to the 5’ or 3’ of the sensor, as the case may 
be. The sub-cellular locations, position (N or C-terminal) and the amino acid targeting 
sequences are given below: 
Table 4.1: Details of targeting sequences  
Subcellular location Position Sequence 
Non-lipid raft plasma membrane C K K K K K S K T K C V I M 
Lipid rafts N G C I K S K R K D K D P 
Nucleus C P K K K R K V E D A 
Cytosol C E F L P P L E R L T L 
Outer mitochondrial membrane N M A I Q L R S L F P L A L P G M L A L L G W 




4.4.2 Cell culture 
PC12 cells were seeded onto sterilized glass coverslips in 35-mm dishes and grown to 
50–90% confluency in DMEM (10% FBS) at 37°C with 5% CO2. Cells were transfected using 
Lipofectamine 2000 (Invitrogen) and grown for 48 h after transfection before the imaging. 
4.4.3 Imaging  
Cells were washed twice with HBSS (Hanks' balanced salt solution) buffer and 
maintained in the dark at room temperature.  
4.4.4 Epifluorescence Microscopy  
Cells were imaged on a Zeiss Axiovert 200M microscope with a cooled charge-coupled 
device camera (MicroMAX BFT512, Roper Scientific, Trenton, NJ) controlled by 
METAFLUOR 6.2 software (Universal Imaging, Downingtown, PA). Yellow/cyan emission 
ratio imaging used a 420DF20 excitation filter, a 450DRLP dichroic mirror and two emission 
filters (475DF40 for CFP and 535DF25 for YFP) alternated by a filter-changer Lambda 10-2 
(Sutter Instruments, Novato, CA). Exposure time was 50–500 ms, and images were taken every 
30s. Fluorescence images were background-corrected by subtracting the fluorescence intensity 
of background with no cells from the emission intensities of cells expressing fluorescent 
reporters. The ratios of yellow/cyan emissions were then calculated at different time points. 
Both Yellow/Cyan ratio and RFP intensity of all time courses were normalized by dividing 
each value by the average basal value before stimulant/inhibitor addition. 
4.4.5 Cell adhesion assay 
Cells were dissociated using 0.05 % trypsin and washed once with DPBS (Dulbecco 
Phosphate Buffered Saline). Cells were then resuspended in 1 mL of DPBS and cell count 
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measured. The cells were then centrifuged at 850g for 5 minutes and the DPBS aspirated. Cells 
were then resuspended in 2 mL of serum-free medium. At the same time, 20 L of the green 
fluorescent dye, Calcein-AM was added to the cell suspension in order to label the cells and 
the suspension incubated at 37°C with 5% CO2 for 30 minutes. The cells were then spun down 
and washed twice with DPBS to remove traces of non-labeled dye. The cells were then 
resuspended in serum-free medium and seeded in 96-well plates in quadruplicates for each 
condition at a density of 5x105 cells/mL. Additionally, cells were also seeded in quadruplicates 
at different densities (0, 1x104, 2x104, 4x104, 6x104, 8x104, 10x104, 20x104, 40x104, 60x104, 
80x104 and 100x104 cells/mL) to calibrate cell adhesion as a function of the measured 
fluorescence. The plate was then incubated at 37°C with 5% CO2 for 3 hours to reach steady-
state. The fluorescence was then measured using a fluorescence plate reader. The fluorescence 
for each well was subtracted from the mean background fluorescence (no cells condition). The 
mean fluorescence obtained from the quadruplicates for each condition was then normalized 










Chapter 5 Conclusions 
The ability of cells to recognize, adapt and respond to a wide variety of external 
conditions is critical for regulating various cellular processes including survival.  Typically, 
cells translate such extracellular cues into specific cellular responses through a diverse but 
finite set of signaling proteins.   Given the limited repertoire of signaling molecules, it is 
common for many signaling molecules to be involved in the regulation of multiple cell 
processes. How cells achieve specificity of signaling using such shared sets of molecules 
is a long standing question.  One particular manner in which specificity may be achieved 
is by exploiting the precise spatial localization and temporal dynamics of different 
signaling molecules.  
In the insulin-secreting pancreatic beta cells, intracellular levels of calcium are 
known to oscillate in response to glucose-mediated membrane depolarization (178). Such 
oscillations are thought to regulate the pulsatility of insulin secretion which in turn is 
deemed to be important for glucose homeostasis (80).  In essence, pancreatic beta-cells 
“encode” information in the versatile oscillatory calcium signal. The encoded information 
is however inadequate without the right set of tools to decode it and use it to regulate 
different processes including insulin secretion. We have shown that kinases are eminently 
suitable for this purpose – with a high capacity to “read” the information, process and 
reshape it and ultimately be able to use the decoded signal for various purposes.  
The kinase, PKA not only decodes the calcium signal and oscillates in tandem with 
it but also actively modulates the frequency of the oscillations. Such complex behavior 
enables it to use information that may be embedded in frequency of the signal to carry out 
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a wide range of functions. Particularly, the frequency information is used to determine the 
spatial range of action of PKA.  Another prominent kinase, ERK, on the other hand displays 
strikingly different behavior and means of decoding the calcium signal. While PKA 
faithfully follows the calcium signal, the ERK cascade processes the oscillatory input 
signal to produce an integrated response. This robust response is achieved via sequential 
processing of the calcium signal through a multi-step cascade. As a result, the ERK cascade 
can progressively filter out high frequency “noise” for sustained ERK activation while still 
retaining the dynamical information for use by other signaling molecules. In toto, we 
showed that two different kinases process the same input signal exhibiting varied temporal 
dynamics which in turn can be used to selectively and effectively modulate their respective 
targets.  
Aside from temporal dynamics, kinases exhibit remarkable variation in the spatial 
dimension as well. In the neuroendocrine PC12 cells, we showed that these kinases, PKA 
and ERK talk to each other in a complex fashion to produce distinct behaviors in different 
locations. In response to EGF, ERK activity shows a transient increase in the cytosol and 
nucleus, which is known to be necessary for cell proliferation (58). Strikingly, however, in 
response to the same stimulus, the same signaling molecule, ERK displays a sustained 
response in the plasma membrane which is important for modulating cell adhesion to the 
matrix. Such spatial variations are brought about by different factors including the manner 
of crosstalk of PKA and ERK in these locations. In essence, the cells appear to enhance 
their “computation” power through spatial compartmentation. The same signaling network 
(the PKA-ERK network in this case) may have different topologies in different locations 
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through the use of regulatory molecules, ensuring different system outputs in different 
locations. 
Spatiotemporal dynamics manifests as a result of complex non-linear interactions 
in signaling networks. Monitoring and understanding the spatiotemporal kinase activity 
dynamics detailed above posed a unique set of challenges which we addressed using a 
combination of modeling and experimental approaches. Non-linear systems are intuitively 
difficult to predict. Using mathematical modeling therefore, we were able to predict the 
system responses and generate hypotheses that could be tested on the bench. In order to 
monitor the dynamical aspects of signaling, we extensively used genetically encoded 
fluorescent biosensors. Live-cell imaging using such biosensors enabled us to capture the 
behavior of different signaling molecules in their native milieu. Multiplex imaging, in 
particular, helped us observe not one but two signaling entities at the same time with the 
result that we could directly correlate the system output to its input within the same cell. 
Improvement and widespread use of such techniques will help us expand our capability to 
study spatiotemporal signaling dynamics in future. 
In conclusion, cells employ and use spatial and temporal dynamics of kinase 
signaling to process external information and regulate a variety of processes. 
Understanding the nature and mechanisms of dynamical aspects of signaling not only 
furthers our comprehension of how cells make decisions but could also serve as viable 
therapeutic targets. Targeting specific dynamical features through regulatory molecules 
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